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Introduction
After a long period of development, which stretched back as far as the eighties, a 
swallowable wireless intestinal video capsule became available in 1999 (Given M2A™, 
Yoqneam, Israel; 1). The fi rst reports of human application came from the group of 
Swain et al (2, 3). Since then many papers on the subject have been published. 
The introduction of this thesis gives an overview of the technique of videocapsule 
endoscopy, the applicability and limitations compared to other diagnostic modalities 
and fi nally discusses future developments of this technique. 
Technical aspects
The capsule has a diameter of 11 mm and a length of 26 mm and contains six light 
emitting diodes, a lens, a color camera chip and two batteries (Figure 1). The color 
camera chip can operate at very low levels of illumination and has a wide viewing angle. 
In the rear dome of the capsule a transmitter and an antenna are located. The capsule 
obtains two images per second. When the capsule is swallowed by an individual, it is 
propelled by peristalsis through the human gut. For optimal visualization, the capsule 
is routinely swallowed after an overnight fast. Four hours after ingestion of the capsule 
a light meal and a drink are allowed. The capsule is disposable and fi nally passes with 
the stools. During the procedure patients can move around freely.
Figure 1 Videocapsule and its components: 1. lenshood, 2. lens, 3. LED, 4. videochip, 5. battery, 6. transmitter, 7. 
antenna. (for colour fi gure see page 142)
The signals emitted by the capsule during gut passage are captured by eight aerials 
which are attached to the abdominal wall according to anatomical landmarks (Figure 2).
The strength of the signal received by the individual aerials allows the correlation 
between specifi c video images and anatomical location. The aerials are connected to 
a recording device. The recorder and its battery are worn in a belt around the waist 
(Figure 3).
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Figure 2 The set of aerials receiving the videocapsule signal and the advised positions on the abdominal wall.
(for colour fi gure see page 142)
Figure 3 The belt with the recorder worn around the waist.
(for colour fi gures see page 143)
At the end of the procedure the data can be downloaded to a work station. This takes 
about 2 hours. The pictures taken by the capsule are integrated into a video fi le which 
can be viewed at a variable number of images per second (Figure 4). Best results are 
obtained in a darkened environment because this enhances contrast and visibility 
of small mucosal abnormalities. Images of abnormalities can be selected and stored 
in a separate fi le. Recently, an algorithm was developed for automatic detection of 
predefi ned abnormalities like blood. This software aims to select images with positive 
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fi ndings and reduce the time needed for analysis. The data on the accuracy and clinical 
value of this new tool are sparse but demonstrate a sensitivity of 25 to 37% in the 
detection of relevant abnormalities which were found by the observer (4, 5).
Review of the capsule endoscopy images initially took about 90-120 minutes. In our 
experience the learning curve comprises about ten investigations. The viewing time 
will probably be reduced with increasing experience. Interobserver agreement has 
already been assessed and appears to be high (6).
Practical aspects
Indications
The major accepted indication for VCE is obscure gastrointestinal bleeding. VCE is 
now considered a fi rst line diagnostic tool in the analysis of obscure gastrointestinal 
bleeding after the performance of a gastroduodenoscopy and colonoscopy without 
abnormalities. Suspected small intestinal Crohn’s disease is another accepted 
Figure 4 The screen of the working station for review of the VCE. (for colour fi gure see page 143)
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indication for VCE. It can be valuable in the analysis of unexplained abdominal 
complaints in known IBD patients but also in patients presenting with abdominal pain, 
diarrhoea combined with weight loss and elevation of infl ammatory parameters. In 
the near future the potential indications will increase as a result of ongoing research 
concerning VCE.
Contra-indications
Formally video capsule endoscopy is contra-indicated in patients with a pacemaker or 
other implanted electronic medical device, although some recent papers reported the 
use of VCE in patients with pacemakers without any problems (7-9). 
Prior small intestinal surgery and known intestinal strictures preclude capsule 
endoscopy. It is however not routinely advised to perform small bowel enteroclysis for 
exclusion of intestinal strictures. A new diagnostic tool is the patency capsule, which 
is a capsule composed of lactose which disintegrates 60-100 hours after ingestion. 
If this capsule does not lead to obstruction, VCE can also be performed without any 
problem (10-12). Although the capsule should pass strictures without any problem 
after disintegration, the patency capsule could not pass a stricture in three patients 
leading to surgery in two patients in the study of Delvaux et al (12). Further research is 
needed to establish the value of the patency capsule in routine clinical care. 
Prior gastric surgery like Billroth II resection implies the risk of the capsule entering the 
aff erent loop. This can be prevented by the endoscopic introduction of the videocapsule 
using a Roth net or a specialized VCE delivery system. The capsule is then introduced 
in the eff erent loop under endoscopic view. This technique can also be used in case of 
swallowing diffi  culty in patients with neurological diseases or when passage through 
the esophagus and stomach is problematic, like in motility disorders (13-15).
VCE is now also considered safe in pediatric patients above the age of 10 years although 
the experience is limited (16). Incidentally VCE has been performed in younger children 
after endoscopic positioning of the capsule under anaesthesia (17).
Preparation
The day before the examination, patients are advised to use a liquid diet, followed 
by an overnight fast. The optimal regimen for preparation has not been determined 
yet. Some studies suggest a better visualization of the small intestinal mucosa after 
bowel cleansing (18-20). It has been reported that the transit of the capsule is delayed 
after bowel cleansing implying the risk of an incomplete examination (21, 22). Some 
studies therefore evaluated the eff ect of prokinetic medication on the gastric and small 
intestinal transit time. The transit times were generally reduced after administration 
of metoclopramide or erythromycin (23-26). In one study the use of erythromycin is 
associated with reduced small bowel visualization (24). Because of the heterogeneity 
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of the studies it is not clear in which way bowel preparation should be performed. 
Further studies are needed to determine the quantity of bowel preparation required to 
obtain a good mucosal visualization and maintain patient satisfaction at a high level.
Obstruction caused by video capsule
With a diameter of 11 mm the capsule may obstruct the small bowel in case of strictures, 
infl ammation or tumors. Only few authors mention obstruction necessitating surgery 
(27-29). Bowel obstruction by the capsule does not necessarily cause symptoms 
because the liquid small intestinal content may still pass the capsule although one 
case of symptomatic obstruction of the patency capsule has been described (30). 
Because the long term exposure of the capsule to small intestinal content can lead to 
its disintegration it has to be removed (31). 
The manufacturer of the capsule reports a 0.5% obstruction rate, whereas recent 
published data show a 1.9% obstruction rate (32). Capsule impaction seems to be 
more prevalent in patients taking large amounts of NSAID’s. This may be related to 
chronic intestinal infl ammation with stricture formation (33). Since there may be 
either a positive or a negative publication bias, exact fi gures remain unclear. It appears 
important to address this potential side-eff ect when a patient is informed about 
the procedure and to perform a careful interview concerning medical history and 
symptoms suggestive for intestinal stenosis. 
In case of retention of the capsule in stomach or colon an endoscopic procedure with 
snare retrieval usually solves the problem. In case of retention of the capsule in the 
small intestine, surgery generally reveals major anatomical abnormalities like strictures 
or tumours which would probably have lead to surgery in the near future (34). With the 
advent of double balloon enteroscopy an impacted capsule can also be retrieved from 
the small intestine endoscopically with the possibility of interventions like dilation or 
tissue sampling in the same procedure (35-37).
Results of videocapsule endoscopy
Gastric and small intestinal transit times
Most studies on VCE report gastric and small intestinal transit times. The relevance of 
these data may be questioned. Gastric transit times are measured in the fasting state 
and have no clinical relevance. Small intestinal transit time is a mixture of fasting and 
postprandial propulsion speed since patients take a drink and a light meal 4 hours after 
ingestion of the capsule. In cases with known or suspected delayed gastric emptying, 
further information is needed prior to capsule endoscopy as the investigation is 
useless if the capsule is retained in the stomach. The small intestinal transit time is not 
relevant although temporary abnormalities in the small intestinal transit times may be 
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associated with anatomical abnormalities like tumours or strictures (38).
The most important fact concerning the gastrointestinal transit is the percentage of 
capsules reaching the cecum during the procedure, which varies between 50 and 87% 
in various studies (39-43).
Diagnostic yield of capsule endoscopy in unexplained gastrointestinal bleeding
Most studies on diagnostic yield of capsule endoscopy comprise patients with obscure 
occult/overt gastrointestinal bleeding (OGIB). Combined data from several studies 
report a diagnostic yield of 42-85% (39, 40, 42, 44-49). This is very high because all 
patients were examined extensively by other means before capsule endoscopy was 
applied. Diagnostic yield is however not always clearly defi ned. In the initial studies all 
abnormalities that were found in the small intestine were considered positive in the 
assessment of diagnostic yield. Many studies did not state whether these lesions were 
considered a potential or defi nite lesion responsible for hemorrhage. This probably 
caused bias in assessing diagnostic yield as demonstrated by the decrease of the 
diagnostic yield from about 70% in the initial studies to about 50% in more recent 
studies. 
In an excellent study of Costamagna et al. fi ndings were classifi ed as diagnostic, 
suspicious or negative (44). Findings were considered diagnostic if the observed 
fi nding could explain the signs or symptoms of the patient and helped plan further 
management or were confi rmed by other modalities. Findings were considered 
suspicious if an observed fi nding failed to explain the signs or symptoms of the 
patient, thus necessitating further investigations to evaluate its clinical relevance. 
When no abnormality was detected or if the procedure was inadequate due to the 
presence of intestinal contents it was considered negative. The use of this defi nition is 
recommended in future papers, although follow-up investigation will be the best way 
to determine whether VCE fi ndings were indeed relevant.
Diagnostic yield in suspected small intestinal Crohn’s disease
Videocapsule endoscopy is promising in suspected small intestinal Crohn’s disease, 
with diagnostic yields varying between 44 and 77% (50-55). In patients with suspected 
Crohn’s disease fi ndings considered positive in the assessment of diagnostic yield were 
erosions, ulcers and strictures not explained by NSAID use. Voderholzer et al. recently 
suggested the presence of more than 10 erosions or aphtoid ulcers to be diagnostic of 
Crohn’s disease (56). The variability in diagnostic yield can be explained by diff erences 
in indications for VCE. Capsule endoscopy appears to have a role in patients with 
abdominal pain, diarrhea and weight loss leading to the suspicion of small intestinal 
Crohn’s disease but also in the management of known Crohn’s disease (52). 
The relevance of newly diagnosed Crohn’s disease is clear but also in known Crohn’s 
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disease it is often important to discriminate between symptoms caused by infl ammatory 
bowel disease and irritable bowel disease. The fi ndings of VCE can infl uence the 
decision to start medication or to evaluate the eff ect of treatment which might lead to 
a change in medication. VCE can also be of value in the diff erentiation between Crohn’s 
disease and ulcerative colitis in patients with an indeterminate colitis (46, 52).
Diagnostic yield of capsule endoscopy versus radiological small bowel examination
Several studies tried to compare the diagnostic yield of capsule endoscopy with 
radiological small bowel examination by conventional, Computed Tomography (CT)- 
or Magnetic Resonance (MR)-enteroclysis (44, 57-60). Conventional enteroclysis in 
patients with OGIB has a diagnostic yield of about 21% whereas CT enteroclysis has 
been reported to have a diagnostic yield of 36% (60, 61). Capsule endoscopy has a 
considerably higher yield. This is not surprising since enteroclysis will not detect 
very fl at or mucosal abnormalities. Although newer techniques like MR enteroclysis 
probably have a better diagnostic yield, a recent comparison of VCE and MR enteroclysis 
demonstrated the superiority of VCE in the detection of polyps smaller than 1 cm (62). 
A potential fl aw in the comparison is the fact that previously in most studies on capsule 
endoscopy patients with suspected or known intestinal strictures were excluded 
in order to prevent impaction of the capsule. In the future, the need to perform 
enteroclysis prior to capsule endoscopy will probably disappear because patients 
with capsule obstruction are generally asymptomatic and the capsule can withstand 
the infl uence of intestinal secretions for several months. Beside this, patients with a 
stenosis which cannot be passed by the capsule will probably need surgery soon, 
resulting in a defi nite diagnosis (34). To perform a serious comparison of enteroclysis 
and VCE, studies are needed in which patients with suspected or known intestinal 
strictures are not excluded, but are considered as “positive yield” for enteroclysis. 
Diagnostic yield of capsule endoscopy versus push enteroscopy
Until the advent of video capsule endoscopy, push enteroscopy was the method of 
choice to visualize the mucosa of the upper part of the small intestine. Diagnostic yield 
of push enteroscopy varies widely with the indication. Several studies indicate that 
for OGIB, the yield is between 26% and 47% (63, 64). The diagnostic yield of capsule 
endoscopy is superior to push enteroscopy (6, 65-69). No true comparison between 
both methods is possible since the capsule examines the whole small bowel whereas 
push enteroscopy examines only the upper part. In the study from Appleyard et al. 
studying the detection of beads attached to canine small bowel wall, VCE was superior 
to push enteroscopy (70). This study showed that the superior diagnostic yield of 
capsule endoscopy was caused by detection of beads in the distal small intestine. 
The diff erence in diagnostic yield between push enteroscopy and VCE may disappear 
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when the results of VCE are compared with intra-operative enteroscopy, which off ers 
visualization of the complete small intestine. One study reported a sensitivity and 
specifi city of 95% and 75% for VCE using intraoperative enteroscopy as the gold 
standard (71). This is however very invasive and carries a higher risk of complications. 
A serious advantage of push enteroscopy over capsule endoscopy is that when 
abnormalities are found, biopsies can be taken and therapeutic interventions can be 
carried out. 
VCE and double balloon enteroscopy
Double balloon enteroscopy (DBE) is a new technique for a complete endoscopic 
examination of the small bowel (72-76). By the sequential insuffl  ation and desuffl  ation 
of a balloon on the tip of an endoscope and a balloon on the tip of its overtube the 
endoscope can be entered through the small bowel. Sometimes both oral and anal 
introduction are needed for a complete examination. VCE fi ndings can determine 
whether the procedure should be started by the anal or oral introduction. A recent study 
by Gay et al. demonstrated that anal introduction was indicated if the capsule transit 
time from ingestion to arrival at the lesion was more than 75 % of the total time from 
ingestion to arrival at the cecum (77). During this procedure the tip of the endoscope 
can be steered, the mucosa can be rinsed and air can be insuffl  ated which off ers a 
potential advantage to the visualization by VCE. Beside this DBE off ers the possibility 
for interventions like taking biopsies, coagulation and dilation. Data on comparison of 
DBE and VCE are sparse but suggest a superior diagnostic yield of DBE (78-80). Further 
studies are needed to determine its place in small bowel investigation.
Clinical impact of capsule endoscopy
As demonstrated by several studies mentioned above, video capsule endoscopy has 
a considerable diagnostic advantage over push enteroscopy and radiological small 
intestinal examination. Only few studies address the question whether VCE also has 
clinical implications (40, 81-83). Some studies, performed in Crohn’s disease patients, 
show a very high clinical impact (46). Probably these studies comprise highly selected 
patients which had solitary small intestinal or therapy resistant disease. On the other 
hand, VCE opens a new era of understanding and treating Crohn’s disease since small 
intestinal Crohn’s disease without stenosis was previously diffi  cult to diagnose or 
evaluate.
It is however frequently not clear what “clinical impact” means and the number of 
patients is generally small. In future studies “clinical impact” should be clearly defi ned 
and prospectively examined in larger groups of patients.
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Potential emerging fi els of application
The range of potential indications for video capsule endoscopy is still expanding. It 
is most frequently used for patients with iron defi ciency anemia, where upper and 
lower gastro-intestinal endoscopy did not reveal any abnormalities. Another accepted 
indication is CD of the small intestine. Many new indications are emerging based on 
ongoing research. 
It is suggested that VCE can be useful in the diagnosis of celiac disease (84, 85). Although 
this diagnosis is primarily established by laboratory tests and jejunal biopsy, capsule 
endoscopy can determine the involved area of the small intestine. It is diffi  cult however, 
to diagnose villous atrophy solely by the macroscopic view. Capsule endoscopy can 
become particularly valuable in understanding and managing therapy resistant celiac 
disease and the diagnosis of enteropathy associated T-cell lymphoma (86). 
Several investigators reported the use of VCE in screening patients with familiar 
adenomatous polyps and Peutz-Jeghers polyps which implies possibilities for the 
detection of other small intestinal tumours like adenocarcinoma and gastrointestinal 
stromal cell tumours (87-90). This was already illustrated by some case reports describing 
the detection of solid tumours by VCE (78, 91, 92). Further research should focus on the 
clinical applicability of VCE in the detection of small intestinal tumours like carcinoid 
tumours.  Previous reports studied the eff ects of NSAID’s on small intestinal mucosa and 
its prevention by misoprostol (93-95). Another potential indication is graft surveillance 
after small bowel transplantation for the early detection of rejection (96, 97). Finally, 
VCE can be used as an important research tool. It off ers the possibility to examine 
the small intestine in a non-invasive way. In this way small intestinal manifestations 
of systemic diseases can be examined. VCE can be used to examine the involvement 
of the small intestine in portal hypertension (98, 99). Another systemic disease which 
can be examined by VCE is Hereditary Hemorrhagic Teleangiectasia which frequently 
causes vascular abnormalities in the small intestine (100). As it is relatively non-invasive, 
VCE is an excellent research tool for diseases of the small intestine so new indications 
will defi nitely appear.
Conclusions
Video capsule endoscopy is a very promising new diagnostic tool. It is easy to perform 
and very comfortable for the patient because it is non-invasive and can be performed 
in the outpatient department. Capsule endoscopy has a diagnostic yield of 42-
85% in adequately selected patients which is superior to small bowel X-ray or push 
enteroscopy. The most important disadvantage of video capsule endoscopy is that no 
interventions or biopsies are possible. VCE has become an accepted diagnostic tool 
in the analysis of obscure gastrointestinal bleeding and suspected small intestinal 
Crohn’s disease and new indications are rapidly emerging. 
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This thesis starts with the description of the development, clinical introduction and 
fi rst results of videocapsule endoscopy (Chapter 1). This new technique has in recent 
years rapidly gained acceptance as an important diagnostic tool in the analysis of 
suspected small bowel disease, such as in patients with unexplained gastrointestinal 
bleeding and patients with small intestinal Crohn’s disease. Technical improvements, 
new indications and evolving insights regarding the appropriate clinical application 
made videocapsule endoscopy (VCE) a very relevant clinical research topic. In this 
thesis we address several of the many important questions concerning videocapsule 
endoscopy.
1. The optimal preparation for VCE was unclear. Initially VCE was routinely performed 
after a clear liquid diet and an overnight fast. Some studies however showed that 
bowel preparation improves the quality of the images acquired during this procedure, 
a fi nding that was not confi rmed by others. We therefore performed a randomised 
controlled trial comparing regular preparation and preparation with 1 or 2 litres 
polyethylene glycol solution (Chapter 2).
2. Most early studies leading to the acceptance of videocapsule endoscopy were 
performed in highly selected patient groups. The widespread application of this 
technique in clinical practice may aff ect the diagnostic yield. We assessed the technical 
feasibility, clinical applicability and diagnostic yield of VCE in 250 unselected patients 
in a general hospital, with special attention to the relation of abnormalities at VCE and 
the symptoms of the patient (Chapter 3a). 
To illustrate the use of VCE in clinical practice one of these patients was described in a 
case report (Chapter 3b).
3. Although the diagnostic yield of videocapsule endoscopy is high, most series do 
not report on the impact of VCE fi ndings on clinical management and outcome.  We 
therefore analysed the direct clinical consequences of VCE fi ndings and the clinical 
condition of 150 patients one year after the procedure (Chapter 4). 
4. Videocapule endoscopy off ers the possibility for a complete endoscopic evaluation 
of the entire small intestine. Neuroendocrine tumours (carcinoids) frequently originate 
in the small intestine but the primary tumour is usually very diffi  cult to detect. We 
hypothesised that VCE may enable detection of small intestinal carcinoid tumours. 
We performed VCE in patients with a metastatic carcinoid tumour and an unknown 
primary after previous enteroclysis, abdominal CT scanning and nuclear imaging 
(Chapter 5).
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5. Hereditary Hemorrhagic Teleangiectasia is a disease that can lead to gastrointestinal 
bleeding. These bleeding episodes often originate from the small bowel. Until 
recently the small intestine was not accessible for easy assessment of the presence 
of teleangiectasia. Analysis could only be performed using gastroduodenoscopy or 
ileocolonoscopy, but these invasive techniques only allow visualisation of a small 
proportion of the small bowel. Videocapsule endoscopy is a potentially useful technique 
for the analysis of small intestinal teleangiectasia and fi ndings may guide treatment. 
We investigated the relationship between HHT phenotype, with an emphasis on the 
occurrence of small intestinal teleangiectasia as assessed by VCE, and the genotype. 
These data may have implications for the understanding and clinical management of 
intestinal blood loss in HHT patients (Chapter 6).
This thesis aimed to answer these questions, thus contributing to the knowledge of 
the clinical applicability of videocapsule endoscopy and its potential indications. 
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Abstract
Introduction
Visualization of the small bowel by videocapsule endoscopy (VCE) is frequently 
disturbed by intestinal contents. Diff erent bowel preparations were studied with 
controversial results.
Aim
Determine an adequate and tolerable bowel preparation for VCE.
Methods
Ninety patients were randomized for three preparation regimens. Group A underwent 
VCE after clear liquid diet and overnight fast, group B and C respectively used 1 or 2 
litres of polyethylene glycol (PEG) solution before VCE. For each VCE fi ve segments 
of 10 minutes were selected, at the start of each quartile of the small intestine, and 
the fi fth being the last 10 minutes of the ileum. Mucosal visibility was good if more 
than 75% of the mucosa could be evaluated. All patients answered a questionnaire 
regarding procedure tolerability.
Results
PEG solution led to a signifi cant improvement of the mucosal visualisation. Mucosal 
visibility was good in the terminal ileum in 25%, 52% and 72% in group A, B and C 
respectively. The diagnostic yield did not change signifi cantly. The use of 2 litres PEG 
solution was considered more uncomfortable than no or 1 litre of PEG solution.
Conclusion
One litre of PEG solution improves mucosal visualisation without causing discomfort 
for the patient.
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Introduction
Videocapsule endoscopy (VCE) is a non-invasive diagnostic tool to visualise the small 
intestinal mucosa. It has a high diagnostic yield in patients with obscure gastrointestinal 
bleeding and suspected Crohn’s disease (1-12). Various studies have proven its 
superiority compared to other diagnostic modalities like push enteroscopy and small 
bowel enteroclysis (13-21). Preparation for VCE usually consists of a clear liquid diet and 
an overnight fast. However, this approach does not prevent that VCE is often impaired 
by the presence of small intestinal contents. Therefore several authors have studied the 
eff ect of bowel preparation by means of polyethylene glycol (PEG) or sodium phosphate 
on small bowel visualisation (22-27). The results of these studies were unfortunately 
contradictory. Some studies reported that bowel preparation resulted in an improvement 
of visualisation, whereas others did not fi nd a diff erence in small bowel visualisation nor 
diagnostic yield. Furthermore, only one of these studies had a randomized design (28). 
Other studies were not randomized and generally included small numbers of patients. 
Moreover, bowel cleansing has been reported to increase small bowel transit time, which 
in theory may lead to incomplete mucosal visualization (29). 
We therefore studied the eff ect of three diff erent regimens of bowel preparation on 
mucosal visualization, intestinal transit time and tolerability in a prospective single-
blinded randomized study.
Methods
Patients
Ninety consecutive patients who were referred for videocapsule endoscopy for various 
indications were studied. Patients were randomized using a computer generated list of 
numbers to one of three preparation regimens by one of the investigators (HO). Group A 
used the standard regimen consisting of a clear liquid diet for 12 hours on the day before 
VCE, followed by an overnight fast. Group B received 1 litre PEG solution (Colofort, Ipsen, 
France) the evening before the examination followed by an overnight fast and group C 
used 2 litres of PEG solution followed by an overnight fast. For all patients age, gender, 
body mass index and indication for VCE were registered.
Videocapsule endoscopy
 VCE was performed using the Given Imaging M2A wireless capsule (Yoqneam, Israel) 
as described previously (30). Four hours after swallowing the capsule, a light meal was 
permitted. At the end of the procedure the data were downloaded to a work station 
to be viewed as movie fi le using dedicated software. In all VCE fi les the fi rst image of 
the stomach, duodenum and cecum were marked for calculation of gastric and small 
intestinal transit times.
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Findings were classifi ed as diagnostic, probable or negative as described before (31). 
Findings were considered diagnostic if the observed fi nding could explain the signs or 
symptoms of the patient and helped to plan further management, or were confi rmed 
by other modalities. Findings were considered a probable explanation if an observed 
fi nding failed to explain the signs or symptoms of the patient, but necessitated further 
investigations to evaluate its clinical relevance. When no relevant abnormality was 
detected or if the procedure was inadequate due to the presence of intestinal contents, 
the procedure was considered negative. 
Mucosal visualisation
Each VCE fi le was reviewed by two independent investigators (ST, MS) without 
knowledge of the preparation regimen. Both reviewers had previously reviewed at 
least 100 VCE procedures. Because there is considerable inter-individual variation of 
small bowel length and transit time, the total small intestinal transit time was divided 
into quartiles. In this way small intestinal segments of diff erent patients could be 
compared to each other irrespective of transit time. At the beginning of each quartile 
and at the end of the small intestine segments of 10 minutes were examined. Mucosal 
visualisation was classifi ed into six categories depending on the percentage of the 
mucosal surface which could be visualised in each segment, <5%, 5-24%, 25-49%, 50-
74%, 75-95% or >95%. For statistical analysis mucosal visualisation less than 75% was 
considered as poor visibility and equal to or more than 75% as good visibility. 
Patient burden 
All patients who underwent VCE answered a questionnaire to assess the impact of 
the bowel preparation. Patients were asked if they experienced abdominal pain or 
nausea during bowel preparation and whether the preparation would withhold 
them to undergo the procedure again. The overall convenience and tolerability of the 
preparation and the examination were assessed on a numerical scale between 0 and 
10, with 10 being no burden at all. 
Statistics
Patients were randomised by means of a list with 3 randomly generated numbers. 
Parametric results were compared by analysis of variance (ANOVA). Non-parametric 
data were compared by Kruskal Wallis test. Group proportions were compared with Chi-
square test or Fisher’s exact test where appropriate. Diff erences between groups and 
eff ects in time were analysed by repeated measures ANOVA with post-hoc Bonferroni 
tests. A p<0.05 was considered signifi cant. Interobserver agreement was assessed by 
Kappa statistics. Statistical analysis was performed with the SPSS program version 14.
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Results
Patient data
Ninety patients were analysed (M/F 41/49) with a mean age of 53.6 years (SD 17.8, range 
14-86 year). VCE was performed for the analysis of obscure gastrointestinal bleeding in 
62 patients (69%), for suspected small intestinal Crohn’s disease in 20 patients (22%), 
and for other reasons in 8 patients (9%; Table 1). No signifi cant diff erences regarding 
sex, age and indication for VCE were found between the three groups.
Patient characteristics and VCE results Preparation
No PEG 1 litre PEG 2 litre PEG p
Age (Yrs) 57 ± 19 53 ± 15 51 ± 19 p=0.49
Sex (m/f) 14/16 16/14 11/19 P=0.43
Indication p=0.77
  Obscure GI blood loss 19 (63%) 22 (73%) 21 (70%)
  IBD 9 (30%) 5 (17%) 6 (20%)
  Other 2 (7%) 3 (10%) 3 (10%)
Diagnosis p=0.86
  Defi nite 8 (27%) 6 (20%) 9 (30%)
  Probable 12 (40%) 14 (47%) 10 (33%)
  No diagnosis 10 (33%) 10 (33%) 11 (37%)
Table 1 Patient characteristics, indications and diagnostic yield in the three diff erent preparation groups.
Gastric and small intestinal transit time of the videocapsule
Gastric transit time was 35±63 min. in group A, 33±52 min. in group B and 29±31 min. 
in group C (p=0.88). The small intestinal transit time was 277 ±95 min. in group A, 274 
±89 min. in group B and 248±96 min. in group C (p=0.45). The cecum was visualised in 
27, 28 and 26 patients in group A, B and C respectively (p=0.69).
Mucosal visualisation
In the fi rst 10 minutes no signifi cant diff erence was found for the percentage of patients 
with good mucosal visualisation (p=0.7). In the terminal ileum good visualisation was 
only achieved in 25% of the patients after standard preparation. After preparation with 
both 1 and 2 litres of PEG solution mucosal visualisation of the terminal ileum improved 
to 52% and 72% respectively (p=0.01). In the remainder of the small intestine an 
improvement in the mucosal visualisation was reported after preparation with a PEG 
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solution. Mucosal visualisation steadily and signifi cantly declined towards the terminal 
ileum for all groups (Figure 1; p≤0.01). 
The visibility curves obtained with 1 and 2 litres of PEG solution diff ered signifi cantly 
from the curve obtained with standard preparation (p=0.03 and p<0.01, respectively). 
No signifi cant diff erence could be found between the visibility curves for 1 and 2 litres 
of PEG solution (p=0.47).
Interobserver agreement for mucosal visualisation was high with a kappa of 0.78 (95% 
C.I. 0.73-0.83).
Figure 1 Proportion of patients with good 
visualisation of the mucosa per quartile of 
total small intestinal transit time for the 
three diff erent preparation regimens (■ 
Group A, no preparation;▲Group B, 1 litre 
PEG solution; ● Group C, 2 litre PEG solution; 
Quartile 0: p=0.7; Quartile 1: p=0.02; Quartile 
2: p=0.01; Quartile 3: p=0.05; Quartile 4: 
p=0.01). 
Diagnostic yield of VCE
A defi nite diagnosis was established in 8 patients (27%) in group A, in 6 patients (20%) 
in group B and in 9 patients (30%) in group C (p=0.86; Table 1). In patients with obscure 
gastrointestinal bleeding a defi nite diagnosis was established in 31%, 18% and 23% in 
group A, B and C respectively whereas in suspected Crohn’s disease a defi nite diagnosis 
was established in 11%, 40% and 50% respectively (p=0.58 for group A, B and C; p=0.1 
for group A and C).
Tolerability of the procedure
Patients rated the whole procedure with 7.6, 8.3 and 7.5 for group A, B and C respectively 
(p=0.24). No signifi cant diff erence was observed for the occurrence of abdominal pain 
or nausea with the three diff erent preparation regimens. The preparation regimen was 
rated as 7.8, 7.8 and 6.0 for group A, B and C respectively (p=0.03). Ninety-four percent 
of the patients were willing to undergo the procedure in the future, irrespective of 
preparation regimen.
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Discussion
VCE has rapidly become an accepted method for the evaluation of patients with 
suspected small bowel disease. Unfortunately however, the optimal preparation for 
this procedure is unknown. Although most investigators only prepare patients by a 
clear liquid diet and an overnight fast, this method appears in our study as well in 
others to be associated with poor visibility of the terminal ileum in the majority of 
patients. This is even more important when VCE is used as a diagnostic tool for patients 
with suspected Crohn’s disease.  
To improve mucosal visualisation, some authors evaluated diff erent regimens of 
preparation. A Greek study evaluated 80 patients who were randomized to either 
regular preparation or 2 litres PEG solution (32). In this study the mucosal visualisation 
was good in 90% of the patients after bowel preparation compared to 60% after a clear 
liquid diet and an overnight fast. The diagnostic yield also changed signifi cantly from 
30% to 65% after bowel preparation. In a study from Switzerland 61 patients used either 
regular preparation or 4 litres of PEG solution (33). The overall visibility of the small bowel 
improved after bowel preparation, but the latter was also associated with a shorter 
small intestinal transit time. In a small study from Israel 10 patients underwent VCE after 
standard preparation and 22 patients after sodium phosphate (34). It demonstrated a 
signifi cant increase of the proportion of patients with adequate mucosal visualisation 
from 50% to 96%. The eff ect of bowel preparation on the diagnostic yield was not 
evaluated in these studies. In contrast to these studies which favour bowel preparation 
before VCE, a French study did not fi nd any diff erence on mucosal visibility or diagnostic 
yield with 2 litres of PEG solution compared to a procedure after an overnight fast (35).
In the present study 90 patients were analysed with three diff erent preparation 
regimens. In contrast to previous studies mucosal visibility was not assessed at fi xed 
time points after the capsule passed the pylorus but at relative time points by dividing 
the small bowel in quartiles. In this way mucosal visibility was compared at relatively 
similar levels of the small intestine. It appeared that the mucosal visualisation per 
quartile improved signifi cantly after preparation with PEG solution. In the most distal 
part of the ileum, the use of one and two litres of PEG solution prior to VCE resulted 
in a better visibility. Despite this, the diagnostic yield did not change after PEG bowel 
preparation. This might be explained by the fact that after a clear liquid diet and an 
overnight fast the majority of the small bowel is cleaned adequately or by the fact that 
in the majority of the patients no defi nite diagnosis can be established. As the most 
striking diff erence is observed in the terminal ileum, it is conceivable that a diff erence 
would be found in case of suspected Crohn’s disease. This was confi rmed by our study 
in which a defi nite diagnosis was established more frequently in case of Crohn’s disease 
after bowel preparation with PEG solution. As the indication for VCE might infl uence 
the diagnostic yield and transit times, future studies on the eff ect of bowel preparation 
should focus on particular indications.
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It is not clear whether the preparation regimen infl uences gastric and small intestinal 
transit times. This might be an important issue as a delay in transit time might result in 
an incomplete examination of the small intestine. An Israelian study reported decreased 
gastric and small intestinal transit times and a Greek study reported an increase of the 
percentage of complete small bowel examinations after bowel preparation (36-38). 
Other authors have reported a signifi cant delay of small intestinal transit time or an 
increase of the gastric transit time after the use of a PEG solution (39, 40). In our study 
no diff erence was found for gastric and small intestinal transit times with the three 
preparation regimens. The proportion of patients in whom the cecum was visualized 
by VCE also did not change signifi cantly after bowel preparation.
This is the fi rst study which evaluated both mucosal visibility after bowel preparation 
and the discomfort for the patient. This is an important issue as many people experience 
the use of a large amount of PEG solution as very uncomfortable. Although the large 
majority of the patients in this study would undergo the procedure again irrespective 
of the preparation used, the use of 2 litres of PEG solution was considered to be more 
uncomfortable than the conventional preparation or 1 litre PEG solution.
The present study supports the use of 1 litre of PEG solution as the preparation of choice 
for VCE as this leads to an improved mucosal visualisation without causing discomfort 
for the patient. If VCE is performed with a high a priori suspicion of abnormalities in the 
distal ileum, like in suspected Crohn’s disease, preparation with 2 litres of PEG solution 
can be considered.
Optimal preparation for videocapsule endoscopy
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Abstract
Background
We aimed to assess technical feasibility, clinical applicability and diagnostic yield of 
VCE in a large group of unselected patients.
Methods
VCE was performed with the Given Imaging swallowable capsule. Findings were 
considered diagnostic if the observed fi nding could explain the symptomatology 
of the patient. Findings were considered suspicious if an observed fi nding failed to 
completely explain the patient’s symptoms. 
Results
250 patients were studied. A defi nite diagnosis was made in 95 patients (38%). 
Suspicious fi ndings were noted in 80 patients (32%). No diagnosis was obtained in 
74 patients (30%). The yield of VCE was higher in patients with suspected Crohn’s 
disease. Mean viewing time decreased signifi cantly from 51±14 min. to 30±7 min. after 
reviewing 50 procedures. 
Conclusions
VCE is an important diagnostic tool but a defi nite diagnosis is established in only 38% 
of the patients. The highest diagnostic yield is obtained in patients with suspected 
Crohn’s disease.
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Introduction
Until recently, limited access to the small intestine was obtained by ileocolonoscopy 
or fl uoroscopy guided push-enteroscopy. Complete examination of the small intestine 
was only achieved by an intra-operative enteroscopy. Videocapsule endoscopy is a new, 
non-invasive diagnostic tool to visualize the entire small intestine. It has revolutionized 
our ability to visualize the small intestine. Main indications for visualisation of the 
small intestine are obscure gastrointestinal bleeding (OGIB), suspected small bowel 
Crohn’s disease, and intestinal tumors. Various studies have been performed in highly 
selected groups of patients. These studies reported a diagnostic yield of 55-85% (1-8). 
These excellent results are however met by two reservations. First of all, most of these 
studies came from tertiary referral centers with highly selected patients, a situation 
that is not met in many centers with the current fast spread of VCE. Secondly, in most 
of the reported literature, all abnormalities were considered to contribute to the 
diagnostic yield although it was frequently unclear whether the fi ndings could explain 
the symptoms. 
In many countries VCE has now been implemented in daily practice. It is however 
considered to be a time consuming procedure. Diagnostic tools, like the suspected 
blood indicator, might facilitate and accelerate the review process.
In this study we assessed the technical feasibility, clinical applicability and diagnostic 
yield of VCE in a large group of unselected patients in a general hospital, with special 
attention to the relation of abnormalities at VCE and the symptoms of the patient.  
Methods
Patients and setting
The study was performed in a single, large general hospital. Two hundred and fi fty 
consecutive patients were examined. Data were collected regarding age, sex, use 
of non-steroidal-anti-infl ammatory drugs (NSAID), physical constitution and the 
symptoms of the patients. Indications were divided in fi ve categories. Patients are 
classifi ed as occult gastrointestinal (GI) bleeding in case of iron defi ciency anaemia in 
the absence of visible blood and as overt GI bleeding if blood loss has been visualised 
(9). Both groups together are described as obscure GI bleeding (OGIB). The third group 
comprised patients with known Crohn’s disease (CD) and unexplained symptoms or 
patients with diarrhoea combined with abdominal pain and laboratory abnormalities 
suggesting CD. The fourth group were patients with suspicion of a small intestinal 
tumor. Patients who could not be included in one of these categories were classifi ed 
as other. 
In patients with OGIB, the lowest haemoglobin (Hb) in the year preceding VCE was 
registered and patients were stratifi ed according to this Hb in categories <5.0, 5.0-7.0 
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and >7.0 mmol/l. The time delay between the most recent bleeding episode and VCE 
was registered in case of overt bleeding and categorized as less than 2 weeks or more 
than 2 weeks.
Videocapsule endoscopy
VCE was performed using the Given Imaging M2A wireless capsule (Yoqneam, Israel). 
The capsule contains a lens, 6 light-emitting-diodes, batteries, a transmitter and an 
antenna. The capsule takes 2 pictures per second and the batteries have a lifespan of 
approximately 8 hours. The patient is prepared for the investigation by a clear liquid 
diet for twelve hours, preceding an overnight fast. In the morning the patient swallows 
the capsule which is propelled by intestinal peristalsis. The pictures are transmitted to 
eight antennas on the abdominal wall in a position depending on several anatomical 
landmarks. Four hours after swallowing the capsule, a light meal was permitted.
At the end of the procedure the data were downloaded to a work station to be viewed 
as movie fi le using dedicated software. 
Videocapsule analysis
Each VCE was reviewed by one of four gastroenterologists. Gastric transit time, small 
intestinal transit time, percentage of capsules reaching the cecum and viewing time 
were registered. Findings were divided in 15 diff erent categories as shown in Table 1. 
In case of major fi ndings in more than one category, both fi ndings were registered. 
Findings were considered diagnostic if the observed fi nding could explain the 
symptoms of the patient. Findings were considered suspicious if an observed fi nding 
failed to completely explain the symptoms of the patient. In case of multiple fi ndings 
the most relevant fi nding determined whether they were considered a defi nite 
diagnosis or suspicious fi ndings. If no relevant abnormalities were found and in case 
of an insuffi  cient investigation, VCE was classifi ed as “no diagnosis”(1). Images were 
analysed by the suspected blood indicator (SBI) if available. This is an algorithm 
detecting red pixels suggesting the presence of blood, erythema or infl ammation. For 
every VCE the result of the suspected blood indicator was registered as positive (red 
pixels detected) or negative (no red pixels detected). Findings of SBI were compared 
to the VCE fi ndings of the observer. Relevant fi ndings to be detected by SBI were large 
angiodysplasia, blood, infl ammation and erythema. If the SBI detected red pixels and 
the observer confi rmed the presence of abnormalities that should reasonably be 
detected by SBI, it was considered true positive. In this way performance of SBI was 
classifi ed as true positive, false positive, true negative or false negative, considering 
the observer’s fi ndings as the gold standard. In case of both false negative and false 
positive fi ndings in the same patient, the fi nal result was registered as false negative 
because of the more serious consequence of potentially missing important information. 
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Using these data specifi city, sensitivity, positive predictive value (PPV) and negative 
predictive value (NPV) of SBI were assessed.
Statistics
Parametric results were compared by two-sided Student’s t-test. Data from multiple 
groups were compared by analysis of variance. Group proportions were compared 
with Chi-square test. A p<0.05 was considered signifi cant.
Results
Patients
250 patients (M/F 115/135, mean age 54.9 yrs., range 11-85 yrs.) were studied. Obscure 
gastrointestinal bleeding was the indication in 177 patients (71%) and was divided 
into occult and overt bleeding (150 and 27 patients respectively). In 57 patients (23%) 
VCE was performed because of suspected small intestinal Crohn’s disease and in 9 
patients (4%) for a suspected tumour Table 2.
Findings All patients 
(N=250)
Occult GI bleeding 
(N=150)
Overt GI bleeding 
(N=27)
CD
(N=57)
Angiodysplasia, large 23 (9%) 21 (14%) 1 (4%) 0 (0%)
Angiodysplasia, small 36 (14%) 29 (19%) 4 (15%) 0 (0%)
Aphtoid lesions 4(2%) 3 (2%) 0 (0%) 0 (0%)
Blood 31 (12%) 19 (13%) 10 (37%) 0 (0%)
Erosion 32 (13%) 21 (14%) 4 (15%) 5 (9%)
Ileitis 18 (7%) 5 (3.3%) 0 (0%) 13 (23%)
Insuffi  cient 8 (3%) 3 (2%) 0 (0%) 3 (5%)
No abnormalities 50 (20%) 31 (21%) 2 (7%) 11 (19%)
Other, diagnostic 5 (2%) 3 (2%) 0 (0%) 1 (2%)
Other, irrelevant 24 (10%) 16 (11%) 0 (0%) 7 (12%)
Other, suspicious 1 (6%) 6 (4%) 2 (7%) 4 (7%)
Stomach abnormalities 15 (6%) 7 (5%) 5 (19%) 0 (0%)
Tumor 7 (3%) 4 (3%) 1 (4%) 0 (0%)
Ulcer 17 (7%) 5 (3%) 0 (0%) 11 (19%)
Venectasy 6 (2%) 5 (3%) 1 (4%) 0 (0%)
Table 1 Diagnostic fi ndings at VCE.
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VCE fi ndings
VCE was performed without complications in all but two patients. In one patient the 
capsule was retained in the stomach due to gastroparesis and removed endoscopically. 
In the other patient the capsule was removed from the cecum by colonoscopy after 
6 weeks because of non-passage despite the absence of obstruction. Gastric transit 
time was 44±71 min. and small intestinal transit time was 254±81 min. No signifi cant 
diff erence was found between transit times for the diff erent indications. The complete 
small bowel was visualized in 189 patients (76%). The mean gastric transit time was 
79±127 min. in those patients in whom the small bowel was incompletely visualized, 
compared to 34±40 min. in patients in whom the capsule visualised the cecum 
(p<0.001).
The viewing time ranged from 5 to 75 min. with a mean of 37±14 min. Mean viewing 
time for every ten procedures was calculated for all investigators and decreased 
signifi cantly from 51±14 min. for the fi rst 10 procedures to 30±7 min. for the 50th to 60th 
procedure (p<0.001; Figure 1). Despite the decrease in viewing time, the frequency of 
a defi nite or probable diagnosis established at VCE did not change. 
Figure 1
Indication N (%)
Occult GI bleeding 150 (60)
Previous overt GI bleeding 27 (10.8)
Suspected small intestinal CD 57 (22.8)
Tumor 9 (3.6)
Other 7 (2.8)
Table 2 Indications for VCE
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All patients 
(N=250)
Occult GI bleeding 
(N=150)
Overt GI bleeding 
(N=27)
CD
(N=57)
Defi nite 95 (38%) 49 (33%) 12 (44%) 28 (49%)
Possible 81 (32%) 55 (37%) 14 (52%) 8 (14%)
No diagnosis 74 (30%) 46 (31%) 1 (4%) 21 (37%)
Table 3 Establishment of a defi nite, possible or no diagnosis using VCE.
Diagnostic fi ndings are shown in Table 1. In 36 patients more than one type of 
abnormality was found. VCE was considered insuffi  cient in 8 patients (3%) due to 
retention in the stomach or inadequate visualisation due to intestinal contents. In 14 
patients (6%) abnormalities in the stomach were found.
Findings were labelled as defi nite diagnosis in 95 patients (38%) and as a possible 
diagnosis in 81 patients (32%). In 74 patients (30%) no diagnosis was established 
(Table 3).
A suspected blood indicator was available in 214 patients. SBI had a positive predictive 
value of 63% and a negative predictive value of 78%. Specifi city and sensitivity were 
75% and 68% respectively (Table 4).
All patients 
(N=250)
Occult GI bleeding 
(N=150)
Overt GI bleeding 
(N=27)
CD
(N=57)
Sensitivity 68% 64% 57% 88%
Specifi city 75% 75% 100% 73%
NPV 78% 76% 40% 92%
PPV 63% 63% 100% 61%
Table 4 Diagnostic performance of SBI.
VCE and obscure gastrointestinal bleeding 
VCE fi ndings in occult GI bleeding
150 patients (M/F 73/77, mean age 60 yrs., range 11-85 yrs.) with occult GI bleeding 
were examined by VCE. Mean gastric transit time was 40 min. (SD 56) and mean 
small intestinal transit time was 250 min. (SD 83). The cecum was reached in 119 
patients (79%). These data did not diff er signifi cantly from any other group. The major 
diagnostic fi ndings were angiodysplasia (n=50, 33%), erosions (n=21, 14%) and blood 
(n=19, 13%). A defi nite diagnosis was established in 33% and a possible diagnosis in 
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37% of the patients. In this group, SBI had a PPV of 63% and a NPV of 76%. No relation 
with the use of NSAID’s was found for the presence of ulcers or erosions. 
VCE fi ndings in overt GI bleeding
Previous overt GI bleeding was the indication for VCE in 27 patients (M/F 14/13, mean 
age 66.6 yrs., range 34-84). In 14 (52%) of the 27 patients with overt gastrointestinal 
bleeding VCE was performed within 2 weeks after fi rst presentation. Mean gastric 
transit time was 40 min. (SD 68) and mean small intestinal transit time was 267 min. 
(SD 83). The cecum was reached in 19 patients (70%). The most frequent fi ndings were 
blood (n=10, 37%), angiodysplasia (n=5, 19%) and abnormalities in the stomach (n=5, 
19%). In 12 patients (44%) a defi nite diagnosis was established which was signifi cantly 
more than in the occult GI bleeding group (p=0.01). A possible diagnosis was found in 
14 patients (52%) and in only 1 patient (4%) no explanation for blood loss was found. 
The diagnostic yield increased from 39% to 56% if VCE was performed within 2 weeks 
after bleeding (p=n.s.). In patients with overt bleeding, SBI had a PPV of 100% but a 
NPV of only 40%.
VCE fi ndings and haemoglobin level
Patients with occult GI bleeding had a mean Hb of 5.5 mmol/l (range 2.5-8.7, SD 1.2), 
whereas patients with overt bleeding had a mean Hb of 4.8 mmol/l (range 2.9-7.7, SD 
1.4; p=n.s.). In patients with overt GI bleeding mean hemoglobin level was signifi cantly 
lower in patients with a defi nite diagnosis compared to the groups with a possible or 
no diagnosis (4.1, 5.0 and 6.9 mmol/l respectively, p=0.04). 
When the result of VCE in case of OGIB was stratifi ed according to haemoglobin level 
before VCE (Hb<5.0, 5.0-7.0 and >7.0 mmol/l), a defi nite diagnosis was found in 42, 24 
and 14% respectively (p=0.03; Figure 2). In male patients a defi nite diagnosis was more 
frequent than in female patients (42% vs 27%, p=0.02). On the presumption that this 
diff erence might be attributed to the confounder of menstrual blood loss in women, 
two groups were made with an age above or below 50.5 yrs. because at this age 50% 
of women are post-menopausal(10). In female patients older than 50.5 yrs. a defi nite 
diagnosis was found more frequently than in young women (39% vs 21%, p=0.05).
VCE fi ndings in suspected small intestinal Crohn’s disease
Suspected small intestinal CD was the indication for VCE in 57 patients (M/F 19/38, 
mean age 37 yrs., range 19-73 yrs.). This group contained signifi cantly more women 
(67 vs 50%;p=0.04) and the mean age and Body Mass Index were signifi cantly lower 
than in the OGIB patients (36.5 vs 61.4 yrs; p=0.05 and 23.7 vs 26.7 kg/m2; p=0.04 
respectively). Average gastric transit time in this group was 52±90 min. and mean small 
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intestinal transit time was 259±79 min. The cecum was reached in 41 patients (72%). 
Main diagnostic fi ndings were ileitis (n=13, 23%), ulcers (n=11, 19%) and erosions (n=5, 
9%). No correlation with the use of NSAID’s could be established. A defi nite diagnosis 
was made in 49% of the patients which was signifi cantly more frequent than in case of 
OGIB (35%, p=0.003).  SBI had a PPV of 61% and a NPV of 92% in these patients.
VCE fi nding in patients with suspected small intestinal tumors
VCE was performed to detect a small intestinal tumor in 9 patients (M/F 5/4, mean age 
52.1 yrs., range 24-80 yrs.). Average gastric transit time was 61±61 min. and the small 
intestinal transit time was 231±98 min. The cecum was reached in 56% of the procedures 
which was less than in case of OGIB and CD (78% and 73% respectively;p=n.s.). A defi nite 
diagnosis was established in 33% of the patients in whom the suspicion of a small 
intestinal tumor was confi rmed by VCE. The cecum was not reached in these three 
patients but without any complaints of obstruction. One patient had a small intestinal 
sarcoma, one patient had Peutz Jehger’s polyp and one patient had a small intestinal 
carcinoid tumour. A possible diagnosis was found in 22% and no abnormalities were 
found in 44%. 
Figure 2
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Discussion
Videocapsule endoscopy is a new technique and is increasingly used as a diagnostic 
tool for patients with obscure GI bleeding and suspected small intestinal Crohn’s 
disease. Initial series reported high diagnostic yields varying between 55 and 85%
(1-8). These data strongly promote the widespread use of VCE, but some reservations 
can be made with respect to the fact that most studies came from tertiary referral 
centers with selected cases. In addition, many series consider all abnormalities at VCE 
contributing to the diagnostic yield. In the present study 250 unselected patients 
were analysed who underwent VCE in our hospital for various indications. In our series 
abnormalities were found in 70% of the patients. This is comparable with previous 
studies in which the presence of defi nite and possible diagnosis were taken together
(2-4, 6, 8, 11-13). Although our diagnostic yield appears to be high, a defi nite diagnosis 
was found in only 38%. The remainder of the abnormalities was insuffi  cient to explain 
the symptoms of the patient. In our opinion the diff erentiation of abnormalities 
depending on the relevance for the explanation of the complaints results in a more 
realistic but considerably lower diagnostic yield.
In patients with obscure GI bleeding the major fi ndings were angiodysplasia, blood 
and superfi cial erosions. In the patient with suspected CD the major fi ndings were 
ileitis, ulcers and erosions. In our population the presence of erosions, ulcers and ileitis 
did not have a signifi cant relation with the use of NSAID’s. In case of suspected CD a 
defi nite diagnosis was made more frequently than in patients with OGIB (49% vs 34%; 
p=0.003). The higher diagnostic yield of VCE in patients with suspected CD and more 
frequent clinical implications have been reported previously (4, 11, 14-16).
An important fi nding in our population was the relation between the haemoglobin 
level before VCE and the presence of abnormalities in the small intestine. In patients 
with a haemoglobin level above 7.0 mmol/l, the chance of fi nding a defi nite diagnosis 
was signifi cantly lower than in the other categories. Interestingly a defi nite diagnosis 
was established more frequently in men than in women. This diff erence may in part 
be related to the confounder of menstrual blood loss contributing to anemia and 
suspicion of OGIB. In female patients younger than 50.5 years, a defi nite diagnosis was 
found in only 12% compared to 31% in women older than 50.5 years.
Although many people consider reviewing VCE a time consuming procedure we 
observed an initial viewing time of less than one hour for doctors with endoscopic 
experience. The viewing time is reduced to 30 min. after 50 procedures, which will 
be acceptable in most endoscopy units. Despite this decrease in viewing time the 
frequency of a defi nite diagnosis did not decrease. 
Although the presence of the SBI should facilitate the analysis of VCE we showed a 
sensitivity of  68% and a PPV of only 63%. Although the PPV increased to 100% in the 
group of patients with overt bleeding, the NPV was only 40% in this group. In patients 
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with suspected CD the NPV was 92%. No signifi cant diff erences could be established. 
In one study in 24 patients (18 patients with OGIB and 6 patients with abdominal pain) 
the SBI was reported to have a sensitivity of 26% and a PPV of 90% (17).The sensitivity 
in this study increased to 81% for active bleeding lesions. It was not reported whether 
there was a diff erence in the reliability of SBI in patients with OGIB and abdominal 
pain. This algorithm clearly needs improvement before it can play an important role in 
improving the review process of VCE. 
It is diffi  cult to verify the fi ndings of the videocapsule because a gold standard is still 
lacking. So far the only way to investigate the small bowel was by push enteroscopy, 
enteroclysis or intraoperative enteroscopy. VCE has been compared to push enteroscopy 
(PE) in both animals and humans. PE and VCE performed equally in the detection of 
beads in the proximal ileum of dogs, but VCE was superior in the detection of the distal 
beads (18). Several comparative studies have also been performed in humans (19-24). 
In these studies the diagnostic yield is varying between 19 and 32% for PE and from 
65 to 74% for VCE. In only some of these studies the relation of the fi ndings to the 
symptoms of the patients is described. Although good results of VCE are generally 
reported, cases have been described in which abnormalities were missed by VCE but 
were fi nally found by PE (16). 
In several studies VCE and enteroclysis were compared. Enteroclysis has a low 
diagnostic yield of 3-23% compared to a diagnostic yield of 45-77% for VCE (1, 25-27).
One study in CD patients reported an equal result of VCE and enteroclysis of 70% and 
67% respectively (14). Some studies also reported comparative studies of VCE and CT 
enteroclysis. The superiority of VCE was confi rmed with a yield of 59-77% as compared 
to 22-36% for CT enteroclysis (25-29). Until recently intraoperative enteroscopy off ered 
the only possibility for endoscopic investigation of the complete small intestine. VCE 
fi ndings have been confi rmed at intraoperative enteroscopy in 14/16 patients (88%) 
with OGIB (30). 
Recently double balloon enteroscopy has been introduced in which an enteroscope is 
introduced through the entire small bowel by sequential insuffl  ation and desuffl  ation 
of balloons on the endoscope and an overtube (31, 32). This technique off ers the 
possibility to investigate the ileum without the need of a laparotomy. Prospective 
studies comparing double balloon enteroscopy and VCE might result in a fair 
comparison and a more reliable estimate of the diagnostic accuracy of VCE. 
Conclusion
VCE is an excellent technique with minimal risks and side eff ects. The viewing time 
decreases to 30 min. after 50 procedures. SBI is not reliable enough to play a role in 
reviewing VCE. Young female patients with OGIB have a low diagnostic yield which 
might be attributed to menstrual instead of intestinal blood loss. The diagnostic yield 
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in patients with OGIB increases when the haemoglobin level is less than 7.0 mmol/l. The 
diagnostic yield is highest in case of suspected Crohn’s disease. Although VCE detects 
abnormalities in 70% of the patients in unselected group in a large general hospital, 
the true diagnostic yield of defi nite fi ndings is considerably lower, in our series 38%. We 
advocate a diff erentiation between defi nite and possible diagnoses in future studies 
on VCE performance.
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Abstract
We present a case of a postmenopausal woman with a congenital aortic stenosis. She 
presented with severe iron defi ciency anemia. After negative extensive gastrointestinal 
analysis she was treated for six months with octreotide. After cessation of octreotide, 
anemia rapidly recurred. A second capsule endoscopy and a double balloon 
enteroscopy were performed and an intestinal vascular malformation was found. After 
surgical segment resection the patient had stable normal levels of haemoglobin and 
no complaints during 14 months follow-up.
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Introduction
The source of obscure gastrointestinal bleeding is often diffi  cult to locate. The small 
intestine beyond the ligament of Treitz is the source of bleeding in up to 5% of patients 
presenting with gastrointestinal bleeding (1). In the small bowel angiodysplasia are 
the most common cause of obscure bleeding, followed by neoplasm. Until recently, 
the small bowel was diffi  cult to examine in an eff ective and patient friendly way. 
Small bowel enteroclysis can reveal strictures and tumors, but mucosal abnormalities 
are diffi  cult to detect. Push-enteroscopy allows limited access to the proximal small 
intestine. Intraoperative enteroscopy allows complete examination of the small 
bowel but is very invasive. New endoscopic techniques like videocapsule endoscopy 
(VCE) and double balloon enteroscopy (DBE) now enable complete examination of 
the small bowel. VCE is a wireless non-invasive imaging technique. After ingestion, 
a video capsule takes 2 photographs per second during its journey through the 
small intestine. The main indication is obscure intestinal bleeding which cannot be 
clarifi ed by esophagogastroduodenoscopy and colonoscopy. VCE can only be used as 
a diagnostic tool since no interventions are possible with the capsule. Double balloon 
enteroscopy is a technique in which an enteroscope is introduced from the oral or anal 
route in the small intestine by sequential infl ation and desuffl  ation of two balloons, 
attached to the enteroscope and an overtube. DBE allows the same interventions as 
with conventional endoscopy. At present, the best candidates for the procedure appear 
to be those with obscure bleeding. We present a patient with obscure gastrointestinal 
bleeding and discuss the application of VCE and DBE.
Case report
A 51-year-old postmenopausal woman presented with iron defi ciency anemia. She felt 
tired and dizzy, but never observed overt blood loss and had no abdominal symptoms. 
Her medical history showed a congenital aortic stenosis for which an aortoplasty 
had been performed at the age of 9 years. At the age of 33 years a Bjork Shiley aortic 
valve prosthesis was implanted and acenocoumarol was started. After mechanical 
dysfunction, a Sorin valve prosthesis was implanted 6 years later. Laboratory 
investigation showed a haemoglobin level of 4.2 mmol/l, severe iron defi ciency and 
no signs of haemolytic anemia. Bone marrow evaluation revealed no abnormalities. 
Colonoscopy, gastroduodenoscopy, small bowel follow through, push enteroscopy 
and VCE showed no abnormalities. Oral and intravenous iron supplementation only 
resulted in minor increase of haemoglobin levels. During six months she was treated 
with octreotide (Sandostatin LAR® 20 mg, Novartis) injections under the presumptive 
diagnosis of obscure gastrointestinal bleeding. This resulted in a complete normalisation 
of haemoglobin levels and disappearance of complaints (Figure 1). After cessation of 
octreotide, iron defi ciency anaemia rapidly recurred. Gastroscopy and colonoscopy 
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were repeated, but again revealed no bleeding focus. A second VCE showed a solitary 
ulcerating angiodysplasia in the middle part of the small bowel (Figure 2). DBE was 
subsequently performed and showed a large submucosal polypoid blue-purple 
tumour (Figure 3a). The lesion was marked at the base by submucosal injection with 
Indian ink and lipiodol (Figure 3b) and a surgical segment resection of 15 centimetres 
was performed by a mid-line laparotomy. Histopathological examination revealed a 
large hemangioma-like ectatic vascular conglomerate with variable wall thickness 
(Figure 4). The patient had a quick postoperative recovery and had stable normal levels 
of haemoglobin and no complaints during 14 months follow-up.
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Figure 1 Haemoglobin levels. Horizontal solid bars indicate octreotide treatment (Sandostin Lar® 20mg monthly 
injections).
Figure 2 Images of the second video capsule 
examination at 2 hours and 9 minutes after ingestion 
showing a solitary ulcerating angiodysplasia.
(for colour fi gure see page 144)
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Figure 3 a) Double balloon enteroscopy showing a polypous angiodysplasia. b) The location is marked with 
Indian ink and lipiodol. (for colour fi gures see page 144)
a b
a b
Figure 4 Histopathological examination showed a large hemangioma-like polypous ectatic vascular 
conglomerate, partly thin walled partly thick walled. ( HE staining, objective 2x en 10x)
(for colour fi gures see page 144)
Discussion
Despite examination of the gastrointestinal tract by gastroduodenoscopy and 
colonoscopy the origin of obscure occult bleeding remains unexplained in 10% of 
cases (2). Angiodysplasia in the small bowel are the cause of obscure gastrointestinal 
blood loss in 30-40 percent of these patients (2). These vascular malformations are 
composed of conglomerates of ectatic, dilated, tortuous thin-walled vessels. Their 
pathogenesis is uncertain. Associations with chronic mucosal ischemia, as well as with 
low grade venous obstruction have been suggested and a congenital predisposition 
has also been considered (3-5). The prevalence of gastrointestinal angiodysplasia in the 
general population is unknown. Most of these vascular lesion are detected in patients 
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older than 60 years (3). An association between aortic valve disease and angiodysplasia 
has been recognized for years (Heyde’s syndrome). Evidence is mounting that severe 
aortic stenosis may cause type 2 acquired von Willebrand’s disease. Heyde’s syndrome 
appears to consist of bleeding from previously latent intestinal angiodysplasia as a 
result of acquired von Willebrand’s disease (6, 7). Recently a retrospective analysis of 
3.8 million hospital discharges found a signifi cant association between bleeding due 
to intestinal angiodysplasias and aortic stenosis (7). However, von Willebrand’s disease 
and also its acquired form are very rare and only a positive family history or a typical 
history of recurrent mucosal bleeding episodes from multiple sites (e.g. epistaxis or 
bleeding after tonsillectomy) may lead to assessment of von Willebrand factor.
Octreotide, a synthetic somatostatin analogue, is a peptide shown to markedly reduce 
splanchnic blood fl ow through specifi c sub-type receptors (8, 9). In a study of three 
patients with bleeding due to small intestinal angiodysplasia, octreotide was well 
tolerated and resulted in a decrease or elimination of the need for transfusions. However 
it did not result in regression of the angiodysplastic lesions (10). In another study 17 
patients were treated with octreotide. Treatment stopped bleeding in ten patients 
and a transient improvement was observed in another four patients (9, 10). Therefore 
octreotide may be useful to control bleeding from small bowel angiodysplasia, as was 
also shown in our patient.
VCE is a new non-invasive imaging technique for the entire small bowel. It provides 
good visualization of the small intestinal mucosa. The diagnostic yield for obscure 
bleeding varies between 60 and 92% (2, 11-14) and is now considered an important 
diagnostic tool in case of normal gastroduodenoscopy and colonoscopy. It is superior to 
push enteroscopy, small bowel barium follow through and computerized tomography 
in patients with obscure gastrointestinal bleeding, iron defi ciency anemia and Crohn’s 
disease. Diarrhoea, small bowel tumours and coeliac disease may also become 
important indications (15). A recent study assessed the diagnostic yield of a second 
VCE with a previous negative evaluation. VCE revealed a defi nite or suspected source 
of bleeding in 35% of 20 patients (19). Another study with 24 patients showed a high 
yield of new fi ndings (75%) on repeat capsule endoscopy (20). A report about false-
negative VCE showed reasons for missed lesions like a small intestinal bowel delay of 
capsule transit greater than fi fteen minutes, capsule nonexcretion and dilation of the 
small bowel without food debris (21). However, none of these factors were identifi ed in 
our patient. VCE does have certain limitations, there is no possibility for air insuffl  ation, 
rinsing of tissue, taking biopsies and therapeutic interventions. Due to its patient’s 
friendly nature, VCE will probably be widely used as a “screening tool” whereas DBE 
will be applied when an abnormality is found by VCE or when severe symptoms are 
not explained by VCE. DBE allows visualisation of the entire small bowel and off ers 
the possibility to take biopsies and perform therapeutic interventions. Lesions can 
be marked by submucosal injection of lipiodol or Indian ink (17, 18). Obscure overt 
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gastrointestinal blood loss is the most important indication for DBE. The exact 
diagnostic yield and clinical implications still have to be defi ned. VCE and DBE have 
an important impact on the diagnostic and therapeutic options for gastrointestinal 
bleeding. Both are considered essential components of the diagnostic workup of 
obscure gastrointestinal bleeding (16-18, 22).
Obscure gastrointestinal bleeding gives a high yield of new fi ndings on repeat VCE 
(20), also DBE appears to surpass other imaging modalities (17), so new pathologic 
fi ndings will be possible (23). The combination of VCE and DBE is very important for 
diagnosis and treatment. This case with a large polypous ectatic vascular conglomerate 
clearly demonstrates the usefulness of repeated VCE and DBE in a patient with obscure 
gastrointestinal bleeding.
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Abstract
Background
Videocapsule endoscopy (VCE) has a high diagnostic yield in the analysis of 
gastrointestinal bleeding and Crohn’s disease. Little information is available on the 
impact of VCE fi ndings on clinical care.
Objective
Assess the impact of VCE fi ndings on clinical management and outcome.
Design
Retrospective descriptive study.
Setting
General hospital.
Patients
VCE was performed in 150 patients for gastrointestinal bleeding (n=97), Crohn’s disease 
(n=36) and miscellaneous reasons (n=17).
Main outcome measurements
Clinical consequences were evaluated using a questionnaire and divided in change 
of management or unchanged management. Change of medication, endoscopic 
procedures, surgical procedures, other consequences and avoidance of additional 
investigations were considered a change of management. For all patients an 
assessment of the actual clinical condition and the most recent haemoglobin level 
were registered.
Results
A defi nite diagnosis was established in 34%, a probable diagnosis in 34% and no 
diagnosis in 32%. Management was changed in 38% of patients, increasing to 59% if a 
defi nite diagnosis was established at VCE. No relation between change of management 
and clinical improvement or increased haemoglobin level could be established.
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Limitations
The start of ethinylestradiol/norethisteron in case of teleangiectasia was considered 
as a change of management although controversy on the rationale of this treatment 
exists. 
A more detailed and objective evaluation of the clinical condition should be performed 
to assess the clinical outcome. 
Conclusions
VCE fi ndings have serious impact on clinical practice. VCE in particular leads to a change 
of management in 59% of the patients in whom a defi nite diagnosis is established. 
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Introduction
Until recently complete endoscopic examination of the small intestine was only 
achieved by intra-operative enteroscopy. The only endoscopic access to the small 
intestine was obtained by ileocolonoscopy or fl uoroscopy guided push-enteroscopy. 
Both approaches off ered a limited view of the small intestinal mucosa. Videocapsule 
endoscopy (VCE) is a new, non-invasive diagnostic tool to visualize the entire small 
intestine. The system consists of a wireless capsule that can be swallowed and is 
propelled by peristalsis. It obtains sequential endoscopic images of the small intestine 
that can be reviewed as a movie. 
Main indications for visualisation of the small intestine are gastrointestinal bleeding 
(GIB), small bowel Crohn’s disease, and intestinal tumours. Various studies on the 
diagnostic yield and clinical applicability of VCE have been performed in highly 
selected groups of patients. These studies reported a diagnostic yield of 55-85% (1-8).
VCE was compared to other diagnostic modalities for the small intestine in a large 
meta-analyis which demonstrated that VCE is superior to push enteroscopy and 
enteroclysis in both the analysis of occult gastrointestinal bleeding and suspected 
small intestinal Crohn’s disease (9). This led to the increasing implementation of VCE in 
clinical practice for the investigation of gastrointestinal blood loss or small intestinal 
Crohn’s disease. Little information is available however on the clinical implications of 
videocapsule endoscopy. Frequently VCE reveals minor abnormalities of which it is not 
clear whether they have a causal relation with the patient’s symptoms. Even in case 
of abnormalities at VCE which can reasonably be the cause of the clinical symptoms 
under investigation, the impact on treatment and outcome is largely unknown. In 
order to assess the clinical usefulness of VCE not only the diagnostic yield but also the 
clinical relevance and consequences should be investigated. 
In the present study we therefore analysed the direct clinical consequences of VCE 
fi ndings and the current clinical status of the patients one year after the procedure.
Methods
Patients
For all patients who underwent VCE in the period between January 2002 and January 
2005 data were collected regarding age, sex and the indication of VCE.  None of the 
patients previously underwent major gastrointestinal surgery.
The indication of GIB was divided in occult gastrointestinal bleeding in case of iron 
defi ciency anaemia in the absence of visible blood and overt gastrointestinal bleeding 
if blood loss has been visualised (10). In patients with GIB, the lowest haemoglobin 
(Hb) in the year preceding VCE was registered. The time delay between the most recent 
bleeding episode and VCE was registered in case of overt bleeding and categorized 
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as less than 2 weeks or more than 2 weeks. Patients with Crohn’s disease (CD) were 
categorized in two groups. Patients with known CD were classifi ed as established 
CD and patients with diarrhoea combined with abdominal pain and laboratory 
abnormalities suggesting CD were classifi ed as suspected CD. All other indications 
were classifi ed as other.
Videocapsule endoscopy
VCE was performed using the Given Imaging M2A wireless capsule (Yoqneam, Israel) 
as described previously (11,12). All images were analysed by one of four experienced 
gastroenterologists who each had reviewed at least 50 VCE procedures prior to the 
study. Gastric and small intestinal transit time was calculated and the percentage of 
complete small bowel evaluations was registered.
Findings were considered a defi nite diagnosis if the observed fi nding could explain 
the symptoms of the patient. Findings were considered suspicious and registered as a 
probable diagnosis if an observed fi nding failed to completely explain the symptoms 
of the patient. In case of multiple fi ndings the most relevant fi nding determined 
whether they were considered a defi nite diagnosis or suspicious fi ndings. If no 
relevant abnormalities were found and in case of an insuffi  cient investigation, VCE was 
classifi ed as “no diagnosis” (1).
Questionnaire
One year after VCE a questionnaire was sent to the referring physician. The questionnaire 
evaluated the impact of VCE fi ndings on clinical care. Clinical consequences were 
categorized as change or no change of management. Change of medication, endoscopic 
procedures, surgical procedures, avoidance of additional investigations (e.g. push 
enteroscopy, CT-enteroclysis or nuclear imaging) and other clinical consequences 
were considered a change of management. In case of patients referred for VCE by one 
of the authors the clinical impact was assessed by an independent physician. 
The treating physician was asked to judge the present clinical condition of the patient 
as worse, better or equal as compared to the moment of referral for VCE based on 
general clinical parameters. If VCE had been performed for gastrointestinal bleeding 
the haemoglobin level one year after VCE was registered. All referring physicians were 
asked whether they would refer their patients for VCE for the same indication in the 
future.
For the assessment of the relation of consequences of VCE fi ndings and clinical outcome 
consequences were divided in change of treatment or unchanged treatment. The major 
diff erences with the assessment of management changes concerned the categories 
avoiding additional investigation and the performance of endoscopic procedures in 
IBD patients. These categories were categorized as unchanged treatment as this will 
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not infl uence the clinical outcome. The other clinical consequences were considered a 
change of treatment. 
Statistics
Parametric results were compared by two-sided Student’s t-test. Data from multiple 
groups were compared by analysis of variance. Group proportions were compared 
with Chi-square test or Fisher’s exact test where appropriate. A two-sided p<0.05 was 
considered signifi cant.
Results
Questionnaire
One year after the performance of VCE 166 questionnaires were sent to the referring 
physicians. The response rate was 90.4% (n=150).
Patients
Analysis was performed for 150 patients (M/F 71/79) with a mean age of 54,0 yrs. (SD 19, 
range 11-83). The indication for VCE was occult gastrointestinal bleeding in 84 patients 
(56%), overt gastrointestinal bleeding in 13 patients (9%), established CD in 14 patients 
(9%), suspected CD in 22 patients (15%) and other indications in 17 patients (11%). 
Videocapsule endoscopy
A complete small bowel examination was obtained in 115 patients (77%). The mean 
gastric transit time was 43 min. (SD 75, range 1-480) and the small intestinal transit 
time was 252 min. (SD 87, range 31-484).
A defi nite diagnosis was obtained in 51 patients (34%), a probable diagnosis in another 
51 patients (34%) and no diagnosis was found in 48 patients (32%; Table 1). In case of 
gastrointestinal bleeding a defi nite diagnosis was found in 25 (26%) patients, a probable 
diagnosis in 40 (41%) patients and no diagnosis in 32 (33%) patients as compared to 
respectively 20 (56%), 5 (14%) and 11 (31%) patients in case of CD (p=0.01). If overt 
bleeding was the indication for VCE, a defi nite diagnosis was found in 5 patients (71%) 
when VCE was performed within 2 weeks after clinical presentation and in 3 patients 
(50%) if the delay was more than 2 weeks (p=n.s.). 
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Clinical consequences
VCE fi ndings led to a change of medication in 23 patients (15%), an endoscopic 
procedure in 15 patients (10%), to surgery in 5 patients (3%), avoided additional 
investigations in 6 patients (4%) and had other consequences in 8 patients (5%). 
Unchanged management occurred in 93 patients (62%; Table 2). 
Defi nite Probable No diagnosis
Gastrointestinal bleeding 25 (26%) 40 (41%) 32 (33%)
  Occult gastrointestinal bleeding 17 (20%) 36 (43%) 31 (37%)
  Overt gastrointestinal bleeding 8 (62%) 4 (31%) 1 (8%)
Crohn’s disease 20 (56%) 5 (14%) 11 (31%)
  Established Crohn’s disease 10 (71%) 2 (14%) 2 (14%)
  Suspected Crohn’s disease 10 (46%) 3 (14%) 9 (41%)
Other 6 (35%) 6 (35%) 5 (29%)
Table 1 Diagnosis according to indication for VCE.
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Total 23 (15%) 15 (10%) 5 (3%) 8 (5%) 6 (4%) 57 (38%) 93 (62%)
GI bleeding 11 (11%) 12 (12%) 3 (3%) 3 (3%) 5 (5%) 34 (35%) 63 (65%)
  Occult bleeding 10 (12%) 8 (10%) 1 (1%) 2 (2%) 5 (6%) 26 (31%) 58 (69%)
  Overt bleeding 1 (8%) 4 (31%) 2 (15%) 1 (8%) 0 (0%) 8 (62%) 5 (38%)
Crohn’s disease 12 (33%) 2 (6%) 1 (3%) 3 (8%) 0 (0%) 18 (50%) 18 (50%)
  Established CD 3 (21%) 1 (7%) 1 (7%) 1 (7%) 0 (0%) 6 (43%) 8 (57%)
  Suspected CD 9 (41%) 1 (5%) 0 (0%) 2 (9%) 0 (0%) 12 (55%) 10 (45%)
Other 0 (0%) 1 (6%) 1 (6%) 2 (12%) 1 (6%) 5 (29%) 12 (71%)
Table 2 Clinical consequences according to indication for VCE.
 Clinical consequences according to indication
In case of gastrointestinal bleeding VCE fi ndings led to a change of medication in 11 
patients (11%), a targeted endoscopic procedure in 12 patients (12%) and to surgery in 
3 patients (3%; Table 2). VCE resulted in a change of management in 26 patients (31%) 
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in case of occult GI bleeding and in 8 patients (62%) when VCE was performed for overt 
GI bleeding (p=0.02). If VCE was performed within two weeks after the manifestation 
with overt bleeding the eff ect on management changes did not diff er signifi cantly 
when compared to VCE performed more than 2 weeks after overt bleeding. 
In patients with established Crohn’s disease medication was changed in response to 
VCE fi ndings in 3 patients (21%) and in suspected Crohn’s disease VCE fi ndings led to a 
change of medication in 9 patients (41%). No signifi cant diff erence was found between 
the occurrence of a change of management between suspected and established CD.
Clinical consequences according to a defi nite, probable or no diagnosis
In case of a defi nite diagnosis VCE fi ndings led to a change of medication in 16 patients 
(31%), to the performance of a targeted endoscopic procedure in 9 patients (18%) and 
to surgery in 4 patients (8%; Table 3, Figure 1). In case of a probable diagnosis at VCE 
medication was changed in 5 patients (10%), an endoscopic procedure was performed 
in 6 patients (12%), a surgical procedure was performed in 1 patient (2%), additional 
investigations were avoided in 3 patients (6%), and other consequences were reported 
in 4 patients (8%). A change of management was found in 28 patients (59%) in case of 
a defi nite diagnosis at VCE, in 19 patients (37%) if a probable diagnosis was found at 
VCE, and in 8 patients (17%) if no diagnosis was found (p<0.001).
Defi nite diagnosis Probable diagnosis No diagnosis
Change of management 30 (59%) 19 (37%) 8 (17%)
  Change of medication 16 (31%) 5 (10%) 2 (4%)
  Endoscopic procedure 9 (18%) 6 (12%) 0 (0%)
  Surgery 4 (8%) 1 (2%) 0 (0%)
  Other consequences 1 (2%) 4 (8%) 3 (6%)
  Avoiding additional investigation 0 (0%) 3 (6%) 3 (6%)
Unchanged management 21 (41%) 32 (64%) 40 (83%)
Table 3 Clinical consequences according to a defi nite, probable or no diagnosis.
Clinical consequences and completeness of VCE examination
In 115 patients (77%) the complete small bowel was examined. A defi nite diagnosis 
was established in 37 (32%) of those 115 patients, and the fi ndings led to management 
changes in 41 patients (36%; Table 4). In 35 patients (23%) the small bowel could not 
be completely visualized. In this group of patients VCE yielded a defi nite diagnosis 
in 14 patients (40%) and clinical management was changed in 16 patients (46%). 
The frequency of management changes did not diff er signifi cantly in relation to the 
(in)completeness of VCE examination.
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Clinical condition and haemoglobin level one year after VCE
Information regarding the clinical condition at one year follow-up was available in 
143 (95%) patients. At that time, 74 patients (52%) were in a better condition (Table 
5). In case of a change of management the condition of 31 patients (57%) improved 
whereas in case of unchanged management the clinical condition improved in 43 
patients (48%; p=n.s.). 
Complete Incomplete
Change of management 41 (36%) 16 (46%)
  Change of medication 18 (16%) 5 (14%)
  Endoscopic procedure 11 (10%) 4 (11%)
  Surgery 3 (3%) 2 (6%)
  Other consequences 4 (4%) 3 (9%)
  Avoiding additional investigation 5 (4%) 2 (6%)
Unchanged management 74 (64%) 19 (54%)
Table 4 Clinical consequences according to completeness of VCE examination.
Total Changed treatment Unchanged treatment
Improved 74 (52%) 31 (57%) 43 (48%)
Unchanged 55 (38%) 18 (33%) 37 (42%)
Deteriorated 8 (6%) 5 (9%) 3 (3%)
Died 6 (4%) 0 (0%) 6 (7%)
Table 5 Clinical condition one year after VCE.
Figure 1 Clinical consequences in case of defi nite, probable or no diagnosis at VCE. 
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When VCE established a defi nite diagnosis there was a non-signifi cant trend to an 
improved clinical condition one year after the procedure in 30 patients (65%) compared 
to 23 patients (45%) and 21 patients (46%) respectively if a probable diagnosis or no 
diagnosis was found (p=0.08). 
The mean haemoglobin level one year after VCE was 8.2 mmol/l (SD 1.10, range 4.9-
10.8) in patients with an improved clinical condition and 7.5 mmol/l (SD 1.26, range 4.7-
7) in the other patients (p<0.01). The mean haemoglobin level increased from 5.4 ±1.2 
mmol/l to 7.7±1.3 mmol/l during the follow-up period (p<0.001). In case of a change of 
management the mean haemoglobin level increased from 5.4±1.0 to 7.3±1.1 mmol/l 
but in case of unchanged management an increase of the mean haemoglobin level 
from 5.4±1.3 to 8.0±1.3 mmol/l was also registered (p=n.s. for comparison between 
both groups).
All referring physicians would perform a VCE for the same indication in the future 
regardless whether VCE lead to clinical consequences.
Discussion
Many studies have described the clinical applicability of VCE but were mainly focussing 
on the diagnostic yield. Due to the widely reported high diagnostic yield VCE has now 
been accepted as a routine clinical investigation in gastrointestinal bleeding and is 
also increasingly used in small intestinal Crohn’s disease. Diagnostic yield may be 
overestimated because of the presence of minor abnormalities of the small intestinal 
mucosa which have no relevance for the underlying disease. In more recent papers 
this was overcome by classifying the abnormalities found at VCE either as a defi nite 
diagnosis or a probable diagnosis depending on the chance that the lesions that were 
found had a causal relation with the clinical problem (1, 4, 13-16).The main question 
remaining is whether the fi ndings at VCE have an impact on the management and the 
clinical outcome of the patients who underwent the procedure.
In the present study the consequences of VCE were divided in two categories. A change 
of medication, the performance of a targeted endoscopic or surgical procedure, 
avoidance of additional procedures, and other consequences were considered a 
change of management. In case of change of medication this also included the start of 
ethinylestradiol/norethisteron (Neocon®), which might lead to an overestimation of the 
major clinical consequences as there is controversy on the rationale for this treatment 
of anaemia due to bleeding angiodysplasia (17,18). In all other cases the result of VCE 
was classifi ed as unchanged management, keeping in mind that the results of VCE 
may have been helpful in minimizing the diff erential diagnostic possibilities, which 
may also have reassured the patient or physician. 
In the entire group of patients, VCE led to a change of management in 38% of 
cases. In case of patients with a defi nite diagnosis at VCE, fi ndings had major clinical 
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consequences in 59% of patients. In case of a probable diagnosis or no diagnosis, 
major clinical consequences occurred in 37% and 17% of patients respectively. The 
fact that management changes occurred in the absence of a diagnosis at VCE can be 
explained by the avoidance of push enteroscopy and stopping mesalazine which was 
previously started for suspected small bowel CD. These results are in accordance with a 
study by Saurin et al who reported major clinical consequences in 61% of the patients 
if VCE revealed highly relevant lesions and 23% in case of minor abnormalities (14).
Most studies reported more frequent changes in clinical management. Some small 
studies reported VCE guided management changes in 67-100% of patients (15,19, 20).
The largest series so far report on 96 patients who underwent VCE mainly for GIB 
resulting in a defi nite diagnosis in 42%. This resulted in a change of management in 
83% of patients and in case of a probable diagnosis management was changed in 
35% (21). In this study management changes were endoscopic, surgical or medical 
treatment, the latter including estrogen therapy and discontinuation of NSAID’s. The 
lower proportion of management changes in the present study is probably related 
to less strict selection of patients as we present the largest population in a general 
hospital with a one year follow-up. 
In case of GIB change of management occurs more frequently in case of overt 
gastrointestinal bleeding as compared to occult bleeding (62% vs 31%, p=0.02). 
VCE has a diagnostic yield of 40-72% in CD (4, 23-28). In a study of 50 patients with 
known or suspected CD a defi nite diagnosis was found in 40% of patients with clinical 
improvement in 17/20 (85%) patients after a change of treatment. A German study 
reported the presence of a defi nite diagnosis in 25/41 patients (61%). In 40% of these 
patients therapy was changed leading to a subsequent clinical improvement (28).
This is in accordance with our results which showed a diagnostic yield of 56% and a 
change in management in 50% of patients. 
We corroborated the fi nding that VCE performed for small intestinal CD led to more 
frequent major clinical consequences than in case of gastrointestinal bleeding 
although this diff erence did not reach statistical signifi cance in our study. 
A complete examination of the small bowel is considered an important advantage 
of VCE when compared to other techniques. Surprisingly we did not fi nd signifi cant 
diff erences with respect to diagnostic yield and clinical consequences between 
complete and incomplete VCE examination. This could either be due to a type II error 
or by the fact that even an incomplete VCE still visualizes the major part of the small 
bowel. Only in case of small intestinal Crohn’s disease major clinical consequences were 
found more frequently in this study in case of a complete small bowel examination 
which might be associated with the predominant location of abnormalities in the 
distal ileum in CD.
Although the establishment of a defi nite diagnosis by VCE led to major clinical 
consequences in 59% of the patients there was only a nonsignifi cant trend towards 
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clinical improvement. The mean haemoglobin level increased during the year 
following VCE but this occurred irrespective of a change of treatment. Although a 
more favourable outcome has been reported for patients in whom VCE yields a defi nite 
diagnosis this could not be confi rmed in our population (14, 19-21). This might be due 
to the fact that the assessment of clinical condition is rather subjective and registered 
one year after the performance of VCE. In future studies a more detailed defi nition of 
the clinical outcome should be used.
In one study only endoscopic procedures, surgical procedures, cessation of non-
steroidal anti-infl ammatory drugs and the start of CD directed therapy were considered 
as a change of management(13). If we apply the same criteria to our population, 34 
(23%) patients would be defi ned as having been subject to treatment changes after 
VCE. This led to clinical improvement in 67% of them as compared to 42% in case of 
unchanged treatment (p=0.06). This improvement in clinical condition was however 
not accompanied by a signifi cant change in the haemoglobin level one year after VCE. 
The application of more strict criteria therefore does not change our observation that 
treatment changes did not lead to a signifi cant improvement of clinical condition one 
year after VCE, although a trend towards signifi cance was observed.
To our knowledge this is the largest study on the clinical implications of VCE. It 
demonstrates that VCE has a high clinical impact with a change of management in 
38% of patients overall, and in 59% when VCE yields a defi nite diagnosis in particular. 
Besides the potential impact on clinical management VCE can be useful for the 
exclusion of major abnormalities of the small intestine. Further studies are mandatory 
to assess the exact clinical role of VCE for several indications with an emphasis on the 
timing of VCE as a diagnostic tool and a more objective and precise assessment of the 
long term clinical outcome.
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Abstract
Objectives
Carcinoid tumours are the most common gastrointestinal neuroendocrine tumours 
(NET). They often originate in the small intestine. The primary tumour is often diffi  cult 
to locate, and resection in an early phase is recommended to prevent complications. 
This study evaluated the value of videocapsule endoscopy (VCE) in the detection of 
small intestinal primary carcinoid tumours. 
Design
Prospective descriptive study.
Setting
Tertiary referral centre.
Patients
Twenty consecutive patients (M/F 13/7; 60.5±9.3 yrs.) with metastatic NET of unknown 
primary.
Interventions
All patients underwent CT-scanning, enteroclysis, nuclear imaging and VCE of the 
small bowel. 
Results
CT-scan and enteroclysis did not detect a primary small intestinal carcinoid tumour. 
Nuclear imaging demonstrated abnormalities in the abdominal area in 13 patients but 
was unable to relate this to an intestinal localisation in any patient. VCE revealed a small 
intestinal tumour in 9 patients. Three other patients showed external compression 
and erosions. At surgery, fi ve patients had a small intestinal carcinoid tumour and in 2 
patients a small intestinal ischemic segment was present.
Limitations
The number of false positive VCE fi ndings is not clear because not all patients 
underwent surgery. The absence of abnormalities at VCE in patients with abnormalities 
at nuclear imaging might be related to the presence of carcinoid tumour restricted to 
the mesenterium or to a false negative VCE.
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Conclusions
VCE has a high diagnostic yield of 45% for identifi cation of primary small intestinal 
carcinoid tumours. Although nuclear imaging had a comparable diagnostic yield it 
could not diff erentiate between intestinal and mesenterial localisation of the carcinoid 
tumour. We suggest VCE as diagnostic procedure of fi rst choice in the search for primary 
intestinal carcinoid tumours.
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Introduction
Neuroendocrine tumours (NET) most frequently (75%) arise in the appendix and 
terminal ileum (1-3). They are usually submucosal tumours with a diameter of 0.5 to 
1.0 cm, and occur in up to 30% of patients at multiple sites in the small bowel. Most 
patients have metastases in the loco-regional mesenteric lymph nodes and liver. 
Early detection and resection of the primary tumour is indicated, even in patients 
with metastatic disease, to prevent complications such as small bowel obstruction, 
bleeding, and mesenteric ischemia on the basis of mesenteric fi brosis (2, 4). However, 
the diagnosis and localisation of small intestinal tumours is diffi  cult with currently 
available techniques. Small bowel follow-through and enteroclysis rarely allow the 
detection of endoluminal tumours smaller than 1.5 to 2 cm (5). Multi detector computed 
tomography (CT) with intravenous contrast may show clearly enhancing submucosal 
lesions, but large series are lacking to report its sensitivity. CT is very accurate in 
detecting mesenteric masses and liver metastases (6, 7). Magnetic resonance imaging 
(MRI) enteroclysis is a rapidly evolving technique. A recent study showed positive 
imaging of small bowel carcinoids in 8 of 12 patients (8). Carcinoids appear on MRI 
either as a mass that enhances with gadolinium, or as a diff use thickening of the bowel 
wall. MRI enables adequate detection of mesenteric masses and liver metastases. 
With In111-pentetreotide scintigraphy primary carcinoid tumours and (liver) metastases 
are detected with a sensitivity of 75% and a specifi city of 100%, comparable to I131- 
metaiodobenzylguanidine (MIBG) scanning (12). The poor spatial resolution of nuclear 
imaging makes it diffi  cult to distinguish a primary intestinal tumour and an extra-
intestinal tumour mass. 
Endoscopy of the complete small intestine has for long remained diffi  cult. Double-
balloon enteroscopy and peroperative enteroscopy give access to the entire small 
bowel but are demanding techniques (13-14). Video capsule endoscopy is a non-
invasive method to visualize the entire small bowel. It has been shown to be useful in 
detecting a wide range of small bowel diseases like bleeding foci, Crohn’s disease and 
solid tumours. VCE has been shown to be superior to small bowel follow-through and 
enteroclysis in detecting small lesions (15).
In the present study we aimed to assess the value of video capsule endoscopy for 
detection of the primary small intestinal tumour in patients with mestastatic carcinoid 
disease.
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Methods
Patients
Twenty consecutive patients (M/F 13/7, mean age 60.5, range 44 to 77 years) with 
metastatic carcinoid tumour diagnosed by histology or cytology were examined. All 
patients were analysed by enteroclysis, CT-scan of the abdomen, nuclear imaging by 
In111 pentetreotide scintigraphy and/or I131 MIBG scintigraphy. One patient (no. 7) also 
underwent ileocolonoscopy demonstrating a multifocal carcinoid tumour in the distal 
ileum. Because carcinoid tumours are frequently present at multiple sites of the small 
intestine, VCE was performed for a complete small bowel evaluation. In addition, a VCE 
was performed in all patients as part of routine clinical care.
Laboratory measurements
5-hydroxyindole-3-acetic acid (5HIAA) was measured using an enzyme ligand 
immunosorbent assay (DRG Instruments GmbH, Germany) in 24 hrs urine collected 
in bottles with 6N HCl as preservative (16). Normal values were 5-40 μmol/day. 
Chromogranin A concentrations were measured in serum using a sandwich radio-
immunoassay (CIS Biointernational, France). Normal values were 10-100 μg/l (17). 
CT-scan
CT scans were performed using a Philips AVE Expander, single-slice-scanner, until 2004. 
A slice-thickness of 7 mm and table-speed of 10mm per rotation were used with a 
reconstruction interval of 5mm. From 2004 a Siemens Sensation open, 20 slice-scanner 
was used with a slice-thickness of 5mm, table-speed 5mm per rotation (1 second) and 
a reconstruction interval of 1,5mm. Intravenous contrast (Omnipaque 300, Amersham 
health, USA) was given in a quantity depending on body weight.
Radionuclide imaging
The patients received 37 MBq (1 mCi) of I131-MIBG by intravenous injection over 5 
minutes. Total body imaging was performed after 24, 48 and 72 h. For somatostatin 
receptor imaging, 110 MBq (3 mCi) In111-pentetreotide (Octreoscan, Mallinckrodt, USA) 
was administered intravenously. Total body imaging was performed at 24 h (18).
Enteroclysis
Under fl uoroscopy a naso-enteral tube (Bilbao-Dotter Hypotonic Duodenography 
Set, Cook, USA) was positioned distal in the duodenum or proximal jejunum. The 
examination was performed using fl uoroscopy and digital spot fi lming during infusion 
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of 600cc Micropaque 100% suspension diluted with 300cc water, until the colon was 
reached (15-60 minutes).
Videocapsule endoscopy
VCE was performed using the Given Imaging M2A wireless capsule (Yoqneam, Israel) 
as described previously (19). Patients were prepared for the investigation by a clear 
liquid diet for twelve hours, preceding an overnight fast. Four hours after swallowing 
the capsule, a light meal was permitted.
All VCE procedures were reviewed by two experienced endoscopists (S.v.T. and 
M.S.) who previously performed at least 150 VCE procedures each. The presence of 
ulceration, submucosal masses and evidence of external compression were considered 
to be suggestive for the presence of a carcinoid tumour. 
Statistics
The diagnostic yields of each method were compared with Chi-square test or Fisher’s 
exact test where appropriate. A two-sided p<0.05 was considered signifi cant. 
Results
Twenty patients with a metastasized carcinoid tumour and unknown primary were 
analysed. Eight patients had metastatic lesions in the liver, 7 patients had both liver 
and mesenteric lesions. In 4 patients only mesenteric abnormalities were present. One 
patient had a multifocal carcinoid tumour in the distal small intestine at ileocolonoscopy. 
Diagnosis was confi rmed by liver biopsy in 14 patients, by cytological examination of 
the mesenterium in two patients, by mesenteric lymph node excision biopsy in one 
patient and by ileal biopsies in one patient. In two patients the initial diagnosis was 
made after CT scan and analysis of 5-HIAA level. In these patients the diagnosis was 
confi rmed histologically after resection of the small intestinal tumour. 
5-HIAA and chromogranin A level
The mean 5-HIAA level (determined in 15 patients) was 848 (SD 372, range 29 to 1354) 
μmol/day. Chromogranin A was determined in 3 patients with a mean value of 273 
μg/l (SD 212, range 74 to 499).
Enteroclysis
All patients underwent enteroclysis. No small intestinal lesions were observed in any 
patient. In one patient retraction of the small intestine due to mesenterial lesions was 
seen (Table 1). 
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Abdominal CT and nuclear imaging 
In 13/20 (65%) and 7/16 (44%) patients an abdominal hotspot (liver not included) was 
found at pentetreotide and MIBG-scintigraphy respectively. In 10/13 (77%) patients with 
positive fi ndings at pentetreotide scintigraphy a mesenterial lesion was found and 1 had 
an abnormality in the cecal region at CT scanning. Positive fi ndings at MIBG scintigraphy 
were related to mesenteric lesions in 6/7 patients. Pentetreotide scintigraphy showed 
the presence of liver metastases in 16/20 (80%) patients, which was confi rmed by CT-
scanning in 15 patients. MIBG scintigraphy demonstrated liver metastases in 10/16 (63%) 
patients which were confi rmed by CT scanning in 9 patients.
Videocapsule endoscopy
All patients underwent videocapsule endoscopy. The capsule was introduced 
endoscopically in one patient because of swallowing diffi  culties. In two other patients 
VCE was repeated with endoscopic positioning beyond the pylorus because the capsule 
remained in the stomach for 7 hours at the fi rst examination. One of these patients had 
external compression of the small intestine at VCE. When excluding the two patients 
in whom the capsule remained in the stomach on fi rst investigation, the mean gastric 
transit time was 17±17 min. The mean small intestinal transit time in all patients was 
283±116 min. The cecum was visualised in 13 patients (65%) and in all patients the 
capsule was expelled naturally. VCE demonstrated abnormalities in the small intestine 
in 12 patients. One or more submucosal tumours were seen in 9 patients (Figure 1A-C), 
external compression in 2 patients (Figure 1D) and mucosal erosion in one patient. The 
diagnostic yield did not change when the cecum was not visualised.
Figure 1 Submucosal mass in the ileum, fi nally 
diagnosed as a small intestinal carcinoid tumour 
in three diff erent patients (A, B, C). Ischemic small 
intestinal segment due to external compression 
by a mesenteric carcinoid tumour (D).
(for colour fi gure see page 145)
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VCE and other diagnostic procedures
Eight patients had no abnormalities at VCE. Four of these patients had a mesenteric 
location of the carcinoid tumour at CT-scan and in one patient an aspecifi c enhancement 
of the distal small bowel wall was seen. Nuclear imaging of the VCE-negative patients 
demonstrated the presence of an abdominal hotspot (liver not included) in 7/8 patients 
(88%) at pentetreotide scintigraphy and in 4/8 patients (50%) at MIBG scintigraphy. All 
patients with a positive VCE had a normal enteroclysis. The diagnostic yield of VCE was 
signifi cantly higher than that of enteroclysis (p< 0.001).
Twelve patients had abnormalities at VCE suggesting the presence of a primary small 
intestinal carcinoid tumour location. Five of these patients (42%) had a normal CT 
and the other patients had only mesenteric abnormalities. In 2/7 (29%) patients with 
mesenteric abnormalities at CT, external compression was found at VCE.  The diagnostic 
yield of VCE was signifi cantly higher than that of CT (p< 0.001).
Pentetreotide scintigraphy was negative in 6/12 (50%) of the VCE-positive patients. 
In 8/12 patients also a MIBG scintigraphy was performed which was only positive 
in 3 patients. The diagnostic yield of VCE as compared to MIBG and pentetreotide 
scintigraphy did not diff er signifi cantly (p=0.3 and p=0.1 respectively). In 5/12 (42%) 
patients with a positive VCE both CT and nuclear imaging were normal. The fi ndings of 
VCE, CT and nuclear imaging are plotted in a Venn-diagram (Figure 2).
Figure 2 Venn diagrams showing the distribution of VCE and scintigraphic fi ndings (A) and VCE and 
CT fi ndings (B).
VCE and surgery
Seven patients with positive fi ndings at VCE (58%) underwent surgery 2.1 months 
(range 1-4) after VCE. In one patient a multifocal ileal carcinoid tumour was found 
over a length of 3 metres, as suggested by VCE. Resection was not performed because 
of the length of the segment. In this patient ileocolonoscopy with biopsy sampling 
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confi rmed the presence of a multifocal carcinoid tumour in the distal ileum. In 
two patients a resection was performed of a segment of small intestine which was 
ischemic due to external compression by a mesenteric carcinoid tumour. One patient 
died postoperatively due to severe ischemia of the small intestine (patient 14). In four 
patients a segment of small intestine was resected in which a primary small intestinal 
carcinoid tumour was found at histopathologic examination. Two of these patients also 
underwent additional treatment for liver metastases by radiofrequency ablation or 
hemihepatectomy during the same procedure. In all patients who underwent surgery 
the fi ndings of VCE were confi rmed. Three patients will be scheduled for surgery, the 
other patients are managed medically.
Discussion
Videocapsule endoscopy is a new diagnostic technique which allows non-invasive 
visualization of the small intestine. In various series of selected patients with suspicion 
of small bowel disease the diagnostic yield varied between 55 and 69% (19). The main 
indications for VCE are obscure gastrointestinal bleeding and suspected Crohn’s disease 
of the small bowel. Some abstracts and case-reports have reported the successful use 
of VCE to detect small intestinal tumours (20-25). In one abstract a small series of seven 
patients with a metastatic carcinoid tumour was studied. VCE diagnosed a primary 
tumour in 5 patients (71%). One patient underwent surgery which confi rmed the VCE 
fi ndings (25).
Intestinal carcinoid tumours are generally smaller than 1 cm. and diffi  cult to detect. 
At initial presentation, many patients already have metastatic lesions in the liver or 
mesentery. The presence of a small intestinal carcinoid tumour frequently leads to 
abdominal complications like intestinal ischemia, bleeding or obstruction. Makridis et 
al described 138 patients with small intestinal carcinoid tumours leading to abdominal 
surgery for abdominal complaints in 51 of them (4). Because of the high risk of 
abdominal complications, resection of the primary tumour is advocated by experts 
even in metastatic disease for palliative purpose (2).
In the present study VCE demonstrated the presence of abnormalities in the 
small intestine in 12 of 20 patients (60%) who had been examined extensively and 
appeared to have a metastatic carcinoid tumour but an unknown primary. All patients 
previously underwent enteroclysis, CT-scan of the abdomen and nuclear imaging 
and in one patient a colonoscopy was also performed. CT-scan and enteroclysis 
had not demonstrated evidence of a primary small intestinal tumour. Nuclear 
imaging frequently showed accumulation of nuclear activity in the intestinal region. 
Pentetreotide scintigraphy even had a higher diagnostic yield than VCE but without 
diff erentiation between intestinal and mesenteric localisation. Performing a resection 
of a mesenterial mass based on scintigraphy alone is therefore associated with the 
risk of leaving the primary small intestinal tumour in situ. The fact that 7 patients with 
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abnormalities at pentetreotid scintigraphy had a normal VCE might be explained by 
abdominal carcinoid tumour localisation restricted to the mesentery or by a false 
negative VCE. 
VCE has been compared previously to enteroclysis and CT scan of the abdomen in a 
heterogeneous group of 52 patients. In the majority of patients VCE was performed for 
obscure gastrointestinal bleeding (15). In patients who underwent enteroclysis (n=40) 
VCE had a diagnostic yield of 55% compared to 3% at barium study. Twelve patients 
were analysed by CT with a diagnostic yield of 21% whereas VCE had a diagnostic yield 
of 63% in these patients. Although the development of multidetector CT-scanning 
allowing thinner collimation and faster scanning will probably improve it’s accuracy, a 
recent comparison of VCE and CT-enteroclysis also showed that VCE was superior (26). 
In this study a  heterogeneous group of 22 patients was investigated. Only one patient 
of this group had a metastatic carcinoid tumour with an unknown primary which was 
neither detected by VCE and CT-enteroclysis. 
Combining nuclear imaging and spiral CT-scan by image fusion is a promising new 
technique. Pfannenberg et al. investigated 54 patients with a suspected or histologically 
proven neuroendocrine tumour using both nuclear imaging and CT-scan (27). Side by 
side analysis of CT and nuclear imaging had a diagnostic accuracy of 99% compared to 
75 and 84% for spiral CT-scan and nuclear imaging alone respectively.
Experience with MRI in the diagnosis of small bowel tumours is limited. One study 
demonstrated the presence of a small intestinal carcinoid tumour in 8/12 patients 
(67%) using abdominal MRI (8). MRI has been compared to VCE in the detection of 
polyps in 20 patients with Peutz-Jeghers syndrome or familial adenomatous polyposis. 
In this study VCE and MRI performed similar in the detection of polyps bigger than 
15 mm., but for smaller lesions VCE was superior (28). Schulmann et al studied 11 
patients with Peutz-Jeghers syndrome using VCE and 4 patients were also studied by 
MR enteroclysis (29). In one patient the polyps detected by VCE were missed by MR 
enteroclysis. The yield of MRI may improve with newer MR enteroclysis techniques (30).
Seven patients in our study underwent surgery for suspected small bowel pathology. 
An excellent correlation was seen between the result of VCE and the fi ndings at surgery. 
Two patients were suspected to have ischemia due to external compression which 
was confi rmed at laparotomy. In one patient a long segment of multifocal tumour was 
diagnosed at VCE in the mid-ileum and at laparotomy this segment with carcinoid 
tumour appeared too long for resection. In the other four patients the location of 
the tumour was in agreement with the VCE fi ndings. In all resection specimens the 
presence of a carcinoid tumour was confi rmed by histopathologic examination. In 
patients who underwent surgery, no false-positive results were obtained by VCE. 
When VCE is negative, repeating the procedure might be considered. A recent study 
in patients with occult GI bleeding demonstrated the presence of abnormalities in the 
small intestine in 35% at repeated VCE after a normal initial investigation (31).
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Our results strongly suggest that patients with a metastatic carcinoid tumour and an 
unknown primary tumour should undergo VCE. In patients with a suspected primary 
tumour at VCE, resection can be performed if the patient is suitable for surgery. 
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Abstract
Introduction
Hereditary hemorrhagic teleangiectasia (HHT) is an autosomal dominant disorder with 
mucocutaneous teleangiectasia and visceral arteriovenous malformations. Mutations 
of endoglin and Activin A receptor like kinase-1 have diff erent phenotypes, HHT1 
and HHT2 respectively. The gastrointestinal tract is frequently aff ected but limited 
information is available on the relation with genotype.
Aim
Determine whether diff erent genotypes have diff erent phenotypes with respect to 
intestinal teleangiectasia.
Methods
HHT patients, referred for anaemia, underwent videocapsule endoscopy. Chart review 
was performed for information on genotype and HHT manifestations. 
Results
25 patients were analysed (M/F 14/11, mean age 49±17 yrs.), 14 HHT1, 8 HHT2 and 3 
without known mutation. Epistaxis occurred in 96% of patients. Gastroduodenoscopy 
revealed teleangiectasia in 7/12 (58%) HHT1 and 3/8 (38%) HHT2 patients. VCE found 
teleangiectasia in all HHT1 and 5/8 (63%) HHT2 patients. In 9/14 HHT1 patients 
teleangiectasia were large. Teleangiectasia in the colon was restricted to 6/11 (55%) 
HHT1 patients. Hepatic arteriovenous malformations were present in 1/7 HHT1 and 
5/6 HHT2 patients. 
Conclusion
Large teleangiectasia in small intestine and colon appear to occur predominantly 
in HHT1. HAVM is mainly found in HHT2. In HHT patients with unexplained anaemia 
videocapsule endoscopy should be considered to determine the size and extent of 
teleangiectasia and exclude other abnormalities.
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Introduction
Hereditary hemorrhagic teleangiectasia (HHT) or Rendu Osler Weber’s disease is a 
hereditary autosomal dominant disorder with variable expression. Teleangiectasia 
are present at characteristic sites like the lips, oral cavity, nose and fi ngers in about 
90% of the patients. Epistaxis frequently is the fi rst manifestation of the disease. The 
gastrointestinal tract is frequently involved but the exact prevalence of intestinal 
lesions is not known (1-3). Gastrointestinal haemorrhage is seen in 10-45% of patients 
(4-6).Other manifestations of HHT are due to visceral arteriovenous malformations 
which can occur in lungs, liver and brain.
So far, mutations of endoglin (ENG; OMIM 131195) on chromosome 9, of Activin A 
receptor like kinase-1 (ALK-1; OMIM 601284) on chromosome 12 and MADH4 on 
chromosome 18 have been demonstrated to be the genetic basis of HHT (7-9).These 
diff erent genotypes have diff erent phenotypes. The ENG mutation predisposes 
to the HHT1 phenotype associated with pulmonary and cerebral arteriovenous 
malformations (PAVM, CAVM; 10). Mutations in the ALK-1 gene, the HHT2 phenotype, 
are associated with a later onset, a milder phenotype and with hepatic arteriovenous 
malformations (HAVM; 10,11).MADH4 mutation is associated with the combination of 
HHT and juvenile polyposis (8).
However, little information is available on the prevalence of gastrointestinal vascular 
malformations in patients with HHT. Teleangiectasies are located preferentially 
in the proximal stomach (12-14). Patients above 50 years are more likely to have 
gastric or duodenal teleangiectasies than patients younger than 50 years (14). Data 
concerning the involvement of the small intestine in HHT are sparse. Until recently, 
complete examination of the small intestine could only be achieved by intra-operative 
enteroscopy. With the advent of videocapsule endoscopy the entire small intestine 
can be visualised in a non-invasive way (15).
We therefore investigated the relationship between HHT phenotype, with an 
emphasis on the occurrence of small intestinal teleangiectasia as assessed by VCE, and 
the genotype. These data may have implications for the understanding and clinical 
management of intestinal blood loss in HHT patients.
Methods
Patients
Twenty-fi ve patients with known HHT based on the Curaçao criteria were selected 
because their medical history revealed anaemia insuffi  ciently explained by epistaxis 
(16). All patients except no. 3, 9 and 20 are a subgroup of the HHT population previously 
described by Letteboer et al (7, 11). A chart review of HHT manifestations was performed 
for all patients. Subgroup analysis was performed for genotype, age and gender. The 
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presence of visceral AVM was established by chest X-ray, abdominal ultrasound, CT-
scanning, MRI or angiography. In patients who underwent gastroduodenoscopy, 
the teleangiectasies were classifi ed depending on the presence in esophagus, 
stomach or duodenum. For description of teleangiectasia in the duodenum data 
from gastroduodenoscopy and VCE were used. If a colonoscopy was performed, the 
presence or absence of teleangiectasia was noted. All patients underwent VCE.
Videocapsule endoscopy
VCE was performed using the Given Imaging M2A wireless capsule (Yoqneam, Israel), 
as described before (17). In brief, a swallowable capsule is propelled by intestinal 
peristalsis taking 2 pictures per second of the intestine. Images are transmitted to 
antennas on the abdominal wall for registration and can be downloaded to a work 
station. 
The VCE images were reviewed by one of four gastroenterologists with extensive 
experience using this technique, without knowledge of the results of HHT mutation 
analysis. Vascular malformations were classifi ed for location (stomach, proximal 
duodenum, small intestine and colon) and for number (none, few (≤5) or multiple 
(>5)). Because the size of the teleangiectasia cannot be measured adequately at VCE, 
they were assessed as large or small. This qualifi cation was re-assessed by a second 
reviewer. In case of large and small teleangiectasia in the same patient, they were 
classifi ed as large. 
Statistics
Parametric results were compared by two-sided Student’s t-test. Group proportions 
were compared with Chi-square test or Fisher’s exact test where appropriate. A p<0.05 
was considered signifi cant.
Results
Patients
Twenty-fi ve patients were analysed (M/F 14/11, mean age 49±17 yrs., range 18-72 
yrs.). Fourteen patients carried the ENG mutation (HHT1) and eight patients the ALK-
1 mutation (HHT2). In three patients the family mutation was not known (HHTx). No 
signifi cant diff erence was found between HHT1 and HHT2 patients concerning age, 
sex and haemoglobin level (Table 1). 
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Arteriovenous malformations of the digestive tract
Teleangiectasia were found in the entire digestive tract in 23/25 patients (92%), at 
gastroduodenoscopy in 14/21 patients (67%), at VCE in 19/25 (76%) and at colonoscopy 
in 6/19 patients (32%). All teleangiectasia in the duodenum that were detected by 
conventional endoscopy were confi rmed by VCE.
Upper digestive tract
Twenty one patients underwent a gastroduodenoscopy. This revealed upper 
gastrointestinal teleangiectasia in 10 (48%) patients. One patient (5%) had a small 
teleangiectasy in the distal esophagus. Ten patients (48%) had gastric teleangiectasies, 
4 of them had large teleangiectasia. Six patients (29%) had duodenal teleangiectasies, 
three of them had both gastric and duodenal teleangiectasia (Table 2 & 3). There were 
no signifi cant diff erences in prevalence of lesions between HHT1 and HHT2.
HHT1 HHT2 p
N 14 8
Age (yrs) 56±14.9 47±13.9 n.s.
Sex (M/F) 7/7 6/2 n.s.
Haemoglobin (mmol/l) 5.8±0.9 5.6±1.6 n.s.
Gastric AVM
Total 7/12 (58%) 3/5 (60%) n.s.
Large 3/12 (25%) 1/5 (20%) n.s.
Small intestinal AVM
Total 14/14 (100%) 5/8 (63%) 0.005
Large 9/14 (64%) 1/8 (13%) 0.02
Colonic AVM
Total 6/11 (55%) 0/7(0%) 0.03
Large 2/11 (18%) 0/7 (0%) n.s.
HAVM 1/7 (14%) 5/6 (83%) 0.02
Epistaxis 13/14 (93%) 7/8 (88%) n.s.
PAVM 9/13 (69%) 0/8 (0%) 0.003
CAVM 2/9 (22%) 0/8 (0%) n.s
Table 1 Phenotypic diff erences between HHT1 and HHT2 patients.
108
Chapter 1 Chapter 4Chapter 3Chapter 2 Chapter 5 Chapter 6
N
Se
x
Ag
e 
(y
rs
.)
H
b 
(m
m
ol
/l)
Ep
is
ta
xi
s
PA
VM
H
AV
M
CA
VM
St
om
ac
h
Ile
um
Co
lo
n
2
M
26
6,
4
+
+
n.
p.
-
N
on
e
M
ul
tip
le
, s
m
al
l
N
on
e
3
F
52
7,
1
-
n.
p.
n.
p.
n.
p.
n.
p.
M
ul
tip
le
, l
ar
ge
n.
p.
4
M
58
5,
6
+
+
n.
p.
-
N
on
e
M
ul
tip
le
, l
ar
ge
N
on
e
6
M
57
5,
3
+
+
-
-
M
ul
tip
le
, s
m
al
l
M
ul
tip
le
, l
ar
ge
M
ul
tip
le
 sm
al
l
10
F
23
7,
4
+
+
-
-
n.
p.
M
ul
tip
le
, l
ar
ge
n.
p.
13
F
42
5,
2
+
+
n.
p.
-
N
on
e
M
ul
tip
le
, l
ar
ge
Fe
w
, s
m
al
l
14
F
18
5,
4
+
-
n.
p.
+
N
on
e
Fe
w
, s
m
al
l
So
lit
ar
y,
 sm
al
l
15
M
46
5,
8
+
+
-
-
M
ul
tip
le
, l
ar
ge
M
ul
tip
le
, l
ar
ge
N
on
e
17
F
52
7,
4
+
+
-
-
Fe
w
, l
ar
ge
M
ul
tip
le
, l
ar
ge
N
on
e
18
M
60
4,
7
+
-
n.
p.
-
N
on
e
M
ul
tip
le
, l
ar
ge
So
lit
ar
y,
 la
rg
e
19
F
51
6,
9
+
+
-
n.
p.
Fe
w
, s
m
al
l
M
ul
tip
le
, s
m
al
l
So
lit
ar
y,
 la
rg
e
21
M
72
4,
9
+
-
n.
p.
n.
p.
Fe
w
, s
m
al
l
M
ul
tip
le
, l
ar
ge
N
on
e
22
M
34
5,
2
+
-
-
+
Fe
w
, l
ar
ge
M
ul
tip
le
, s
m
al
l
Fe
w
, s
m
al
l
23
F
60
5,
6
+
+
+
-
M
ul
tip
le
, s
m
al
l
Fe
w
, s
m
al
l
n.
p.
Ta
bl
e 
2 
H
H
T1
 m
an
fe
st
at
io
ns
 (n
.p
. n
ot
 p
er
fo
rm
ed
)
109
Assessment of intestinal vascular malformations
N
Se
x
Ag
e 
(y
rs
.)
H
b 
(m
m
ol
/l)
Ep
is
ta
xi
s
PA
VM
H
AV
M
CA
VM
St
om
ac
h
Ile
um
Co
lo
n
1
M
72
4,
7
+
-
+
n.
p.
M
ul
tip
le
, l
ar
ge
M
ul
tip
le
, s
m
al
l
N
on
e
7
M
61
3,
8
+
-
-
-
N
on
e
M
ul
tip
le
, s
m
al
l
N
on
e
8
F
43
3,
3
+
-
+
-
Fe
w
, s
m
al
l
N
on
e
N
on
e
9
M
71
7,
5
+
-
+
n.
p.
N
on
e
So
lit
ar
y,
 sm
al
l
n.
p.
11
M
33
6,
5
+
-
+
-
N
on
e
N
on
e
N
on
e
12
M
56
6,
7
+
-
n.
p.
n.
p.
Fe
w
, s
m
al
l
M
ul
tip
le
, l
ar
ge
N
on
e
16
M
50
7,
2
+
-
n.
p.
n.
p.
N
on
e
N
on
e
N
on
e
24
F
67
5,
2
-
-
+
-
N
on
e
Fe
w
, s
m
al
l
N
on
e
Ta
bl
e 
3 
H
H
T2
 m
an
ife
st
at
io
ns
 (n
.p
.: 
no
t p
er
fo
rm
ed
)
110
Chapter 1 Chapter 4Chapter 3Chapter 2 Chapter 5 Chapter 6
Small intestine
All patients underwent videocapsule endoscopy without complications. The average 
gastric transit time was 25±35 min. and small intestinal transit time was 264±91 
min. The cecum was reached in 96%. Small bowel teleangiectasies were found in 
19/25 patients (76%). In all HHT1 patients teleangiectasies were present in the small 
intestine. In 9/14 patients (64%) multiple large teleangiectasies were seen, while the 
other patients had multiple small teleangiectasies. Teleangiectasies were present in 
5/8 of HHT2 patients (63%). Multiple large teleangiectasies were found in 1 patient and 
few small teleangiectasies were found in 4 patients. The occurrence of teleangiectasia 
and large teleangiectasia was therefore more frequent in HHT1 than in HHT2 patients 
(p=0.005 and 0.02 respectively). In 4 patients active bleeding was seen during VCE, 
three of them were HHT1 patients. In 2 HHTx patients multiple small teleangiectasia 
were found and in one HHTx patients VCE was without abnormalities.
Six HHT1 patients were younger than 50 years, three of them had large teleangiectasia 
and the other three had small teleangiectasia. Eight HHT1 patients were older than 
50 years and 7/8 (88%) of them had multiple large teleangiectasies and 1 (13%) had 
multiple small teleangiectasies (p=n.s.). Three HHT2 patients were younger than 50 
years and had no abnormalities at VCE, whereas all 5 patients older than 50 years had 
teleangiectasia (p=0.02). No major abnormalities except teleangiectasia were detected 
by VCE. In one patient the presence of a polyp in the proximal small intestine was 
suggested, which could not be confi rmed by push enteroscopy. In two other patients 
superfi cial erosions in the stomach were found.  
Colon
Colonoscopy was performed in 19 patients. Teleangiectasia were found in 6 (32%) 
patients. Two of them had a solitary large teleangiectasy, one patient a small solitary 
lesion, and 3 had multiple small teleangiectasies. All six patients with teleangiectasia 
belonged to the 11 examined HHT1 patients (55%). None of the HHT2 patients had 
teleangiectasia in the colon (p=0.03).
Liver
HAVM was present in 6 patients. In HHT1 patients 1/7 (14%) had a HAVM and in HHT2 
patients 5/6 (83%) had a HAVM (p=0.02). The presence of a HAVM was not known in 
7 HHT1 patients and in 2 HHT2 patients. The two HHTx patients who were examined 
had no HAVM.
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HHT manifestations outside the digestive tract
Spontaneous recurrent epistaxis was present in 24/25 patients (96%) and no diff erence 
between HHT1 and HHT2 patients was found. PAVM were present in 11 patients (Table 
2 & 3). In case of HHT1 patients 9/13 (69%) had a PAVM whereas in HHT2 patients no 
PAVM was found (p=0.003). Two patients with HHTx had a PAVM. In 1 HHT1 patient and 
in one HHTx patient the presence of a PAVM was not examined.
Eighteen patients were analysed for the presence of a CAVM. CAVM was present in two 
HHT1 patients and in one patient without a known mutation (p=n.s.).
Figure 1 Small intestinal teleangiectasia detected 
by VCE in four diff erent HHT patients.
(for colour fi gure see page 146)
Discussion
HHT is a relatively rare disorder, but many patients aff ected by this disease suff er from 
recurrent occult or overt gastrointestinal bleeding, often leading to anaemia. As a result, 
these patients may be presented to a gastroenterologist for diagnosis and treatment. 
Depending on the site of teleangiectasia, treatment with argon plasma coagulation can 
be considered and in case of diff use abnormalities treatment with estrogens may be 
tried (4, 18-21). Longacre et al also described the possibility of treatment with danazol, 
a weak androgen, or aminocaproic acid which inhibits fi brinolysis (4). There is however, 
limited information on the distribution of teleangiectasia in the small intestine. The 
majority of studies examined patients by gastroduodenoscopy and colonoscopy 
but little information is available on the small intestinal manifestations of HHT as 
this part of the digestive tract was diffi  cult to examine using endoscopic techniques. 
The proximal small intestine can be investigated by push enteroscopy, but for the 
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endoscopic assessment of the entire small intestine until recently an intraoperative 
enteroscopy was mandatory. This is an invasive procedure. Enteroclysis is not reliable 
for the detection of superfi cial mucosal abnormalities like teleangiectasia. VCE is a new 
and non-invasive technique for endoscopic evaluation of the small intestine.
The presence of teleangiectasia in the small intestine of HHT patients as assessed by VCE 
has been reported previously in a single study (22). In this study gastroduodenoscopy 
and VCE were performed in 20 HHT patients without knowledge of the underlying 
mutation. The prevalence of teleangiectasia was reported to be 56% with a preferential 
occurrence of teleangiectasia in older patients.
In the present study teleangiectasia of the digestive tract were found in 92% of patients 
which is much higher as compared to the study of Ingrosso et al. The diff erence will 
probably be explained by selection as our study includes only patients with anaemia. 
Ingrosso et al. describe patients with haemoglobin levels varying between 5.3 and 9.7 
mmol/l and report a lower haemoglobin level in patients with teleangiectasia. Although 
our study also includes colonic teleangiectasia this does not account for the diff erence 
because all patients with colonic teleangiectasia also had gastric or small intestinal 
teleangiectasia. An interesting observation was the absence of teleangiectasia at 
colonoscopy in HHT2 patients whereas teleangiectasia in the colon were found in 
43% of the HHT1 patients. In the small intestine teleangiectasia were found at VCE in 
all HHT1 patients, with large teleangiectasies in 9/14 (64%). In only one HHT2 patient 
a large teleangiectasy was found, 4 HHT2 patients had a few small teleangiectasies. 
Four patients (2, 4, 7 and 24) who were examined in our study had no abnormalities at 
gastroduodenoscopy and colonoscopy but multiple large teleangiectasia at VCE. The 
absence of abnormalities at conventional endoscopy in HHT patients therefore does 
not exclude the presence of large teleangiectasia in the small intestine. 
Based on previous reports, the major confounding factor in the gastrointestinal 
manifestations of HHT is age, because teleangiectasia is more frequent in patients 
older than 50 years (14). The only other study using VCE for the detection of small 
intestinal teleangiectasia also reported that patients without teleangiectasia had a 
mean age of 45 years compared with a mean age of 63 years if teleangiectasia were 
present (22). These fi ndings are compatible with a study by Plauchu et al describing 
324 HHT patients with gastrointestinal bleeding in 15%. Half of the patients were older 
than 58 years at the initial manifestation of gastrointestinal bleeding as compared to 
the manifestation of epistaxis in half of the patients before the age of 20 years (23).
So far no consistent diff erence in the gastrointestinal manifestations of HHT1 and 
HHT2 could be established (10, 11). In a study comparing 39 HHT1 patients and 16 
HHT2 patients, more severe gastrointestinal bleeding was reported in HHT1 patients 
(24). Berg et al describe data from 49 HHT1 patients and 34 HHT2 patients and found 
no signifi cant diff erence for the prevalence of gastrointestinal haemorrhage between 
both groups. A separate analysis of the prevalence of gastrointestinal bleeding in 
patients older than 60 years found predominance for HHT2 patients (37% vs. 11%) 
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although this did not reach statistical signifi cance (10).
Our study found a higher prevalence of large teleangiectasia in HHT1 patients older 
than 50 years, although this did not reach signifi cance. In HHT2 patients the presence of 
teleangiectasia was restricted to patients older than 50 years. Despite the signifi cantly 
higher prevalence of teleangiectasia in the small intestine and colon in HHT1 the level 
of anaemia was comparable in both genotypes. The question remains to be resolved 
if teleangiectasia increase in size and number during life. VCE might be a valuable tool 
to address this issue in a research setting.
It is diffi  cult to determine whether there are true phenotypical diff erences in the 
patients of this study between HHT1 and HHT2 with respect to gastrointestinal 
localisation, because the patients were selected largely on account of anaemia which 
was insuffi  ciently explained by epistaxis. To confi rm the presence of a true phenotypical 
diff erence, a systematic investigation in large groups of HHT patients without anaemia 
should be performed using VCE.
Recently, double balloon enteroscopy (DBE) has been introduced, in which an 
enteroscope is introduced through the entire small bowel by sequential insuffl  ation 
and desuffl  ation of balloons on the tip of the endoscope and an overtube (25, 26). 
This technique allows investigation of the entire small intestine without the need 
for a laparotomy. It off ers the possibility to take biopsies or perform argon plasma 
coagulation of teleangiectasia. This technique might therefore be of relevance for HHT 
patients with unexplained blood loss from teleangiectasies identifi ed by VCE because 
they can be treated by argon plasma coagulation (19, 27, 28). Although solid data are 
sparse there seems to be a good correlation between images obtained by VCE and 
conventional endoscopy. A study by Hartmann et al compared the fi ndings of VCE 
and intraoperative enteroscopy in 47 patients and VCE had a sensitivity of 95% and 
a specifi city of 75%, considering intraoperative enteroscopy as the reference (29). 
One study prospectively compared the fi ndings of VCE and DBE in 35 patients (30). In 
this study VCE demonstrated abnormalities of the small intestine in 28 patients that 
were confi rmed in 20 patients (71%). Further comparative studies of VCE and DBE are 
needed to establish the correlation between both techniques. 
In the present study several patients with severe anaemia (patient 8, 11 and 24) 
showed no or few small intestinal teleangiectasia. Although a negative gastrointestinal 
endoscopy (gastroduodenoscopy, VCE and colonoscopy) in these patients does not 
completely exclude an intestinal source of bleeding, it strongly points to epistaxis as 
the main cause of anaemia. As VCE is now accepted as a diagnostic tool in the analysis 
of obscure gastrointestinal bleeding it should be considered in case of unexplained 
anaemia in HHT patients (31, 32). In this way alternative diagnoses can be excluded 
and in case of large teleangiectasia in the small intestine endoscopic treatment can 
be considered in case of anaemia requiring chronic iron supplementation or frequent 
transfusions. 
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Conclusion
HHT frequently aff ects the digestive tract, resulting in anaemia due to bleeding 
teleangiectasia. Large teleangiectasia in the small intestine and the colon mainly 
occurs in HHT1 patients, whereas HAVM is predominantly present in HHT2 patients. 
This has become more relevant with the emerging possibilities of new endoscopic 
techniques for the treatment of small intestinal teleangiectasia. In HHT patients with 
unexplained anaemia videocapsule endoscopy should be considered to determine 
the size and extent of teleangiectasia and exclude other abnormalities. 
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1. Initially videocapsule endoscopy was performed after a clear liquid diet and an 
overnight fast. Some studies showed that bowel preparation improves the quality of 
the images acquired during this procedure, whereas others did not fi nd any diff erences. 
The best way to prepare patients for VCE had not been evaluated systematically. 
Based on the data presented in chapter 2, one litre PEG based solution should be used 
prior to VCE as this signifi cantly increases mucosal visibility without any discomfort 
for the patient. If special interest exists for the visualisation of the terminal ileum (e.g 
in case of Crohn’s disease), 2 litres of PEG based solution further improves mucosal 
visualisation.
2. Most early studies leading to the acceptance of videocapsule endoscopy were 
performed in highly selected patient groups. The widespread application of this 
technique in clinical practice may have changed the diagnostic yield of capsule 
endoscopy. It is therefore important to determine the applicability of VCE in a large 
population of a general hospital.
The diagnostic yield of VCE strongly depends on the defi nition of the (clinical) relevance 
of the fi ndings at VCE. The diagnostic yield of VCE regarding clinical relevant fi ndings 
was 38% overall in our population. In case of unexplained gastrointestinal bleeding, 
the diagnostic yield was 33%. The severity of the anaemia has a signifi cant relation 
to the diagnostic yield. In patients with suspected small intestinal Crohn’s disease the 
diagnostic yield rises to 49%.
Although the time to review VCE fi ndings initially was 51 minutes, which might be a 
barrier for the clinical applicability, this decreases to 30 minutes after reviewing 50 
procedures.
Based on the diagnostic yield and the viewing time for an experienced reviewer, we 
conclude that VCE is a useful technique for clinical application.
3. Although the diagnostic yield of videocapsule endoscopy is high, the important 
question remains to be resolved whether the fi ndings of this procedure have impact 
on clinical management and outcome.
One year after the performance of VCE patient management appeared to be changed 
by its fi ndings in 38% of the patients. This percentage increased to 59% in those cases 
in whom VCE yielded a defi nite diagnosis. Despite this impact on clinical management 
no improvement of the clinical outcome was found.
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4. Videocapsule endoscopy off ers the possibility for a complete endoscopic evaluation 
of the entire small intestine. Neuroendocrine tumours (carcinoids) frequently originate 
in the small intestine but the primary tumour is usually very diffi  cult to detect. VCE 
may be of important clinical value when searching for the primary tumour.
In the analysis of 20 patients with a metastatic carcinoid tumour with an unknown 
primary, VCE revealed abnormalities suggestive of a primary intestinal carcinoid 
tumour in 12 patients (60%). Seven of these patients subsequently underwent surgery 
which confi rmed the diagnosis of a small intestinal carcinoid tumour. Although the 
diagnostic yield of VCE is comparable to the yield of nuclear imaging techniques, 
the latter generally cannot discern between an intestinal or a mesenterial tumour 
location.
VCE therefore appears to be an essential diagnostic tool in the analysis of patients with 
a metastastatic carcinoid tumour and an unknown primary.
5. Hereditary Hemorrhagic Teleangiectasia is a disease that can lead to gastrointestinal 
bleeding. These bleeding episodes often originate from the small bowel. Until 
recently the small intestine was not accessible for easy assessment for the presence 
of teleangiectasia. Analysis could only be performed using gastroduodenoscopy or 
ileocolonoscopy. Videocapsule endoscopy is a potentially useful technique for the 
analysis of small intestinal teleangiectasia and fi ndings may guide treatment.
In the analysis of 25 HHT patients with anaemia, small intestinal teleangiectasia were 
found in 19 (76%) patients. Small intestinal teleangiectasia were found in all patients 
carrying the endoglin mutation and in 63% of the patients carrying the ALK-1 mutation. 
In 4 patients who previously had undergone a diagnostic gastroduodenoscopy and 
colonoscopy, teleangiectasia had been found in the small intestine. 
We conclude that VCE is an essential technique for the assessment of small intestinal 
teleangiectasia in HHT patients with anaemia. If teleangiectasia are present, VCE 
fi ndings may guide treatment, for example by argon plasma coagulation at double 
balloon enteroscopy.
In this thesis we investigated and subsequently demonstrated the clinical feasibility 
and clinical relevance of video capsule endoscopy. Moreover we demonstrated the 
application of video capsule endoscopy as a powerful tool to extend the knowledge 
of small intestinal pathology. 
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Chapter 1
The recent introduction of videocapsule endoscopy has provided gastroenterologists 
a complete and simple endoscopic technique for endoscopic evaluation of the entire 
small intestine. Previously, the proximal part of the small intestine could be examined 
using push enteroscopy and the terminal ileum could be evaluated at ileocolonoscopy. 
Only an intra-operative enteroscopy off ered the possibility to examine the entire small 
intestine. The latter is however a very invasive procedure as a laparotomy is necessary 
to allow the surgeon to move the small bowel over the endoscope. Videocapsule 
endoscopy (VCE) is a new technique to examine the small intestine in a non-invasive 
way. A capsule with a length of 26 mm. and a width of 11 mm. is swallowed by the 
patient and is propelled by small intestinal peristalsis. It obtains two digital images 
per second which are transmitted to a data recorder. At the end of the procedure the 
images are downloaded to a working station where they can be reviewed as a movie.
The fi rst papers on the results of VCE were very promising. The entire small intestine 
was examined in 85% of the patients and a diagnosis was established in 55-85% of 
the patients. The diagnostic yield in these fi rst studies could be overestimated by the 
initial strong case selection, and the clinical relevance of the VCE fi ndings remained 
unclear. It can be expected that the proportion of patients with clinically relevant VCE 
fi ndings will be lower when the technique is more widely available. Capsule endoscopy 
nevertheless appears to be superior to push enteroscopy and radiological examination 
of the small intestine. Further research is needed on the optimal preparation, clinical 
consequences of VCE fi ndings and possible other indications for VCE.
Chapter 2
Initially, all patients who underwent VCE used a clear liquid diet on the afternoon 
before the examination, followed by an overnight fast. Despite this preparation, VCE 
was frequently disturbed by the presence of small intestinal contents. Although many 
studies demonstrated that the use of polyethyleneglycol (PEG) containing solutions 
improved the mucosal visualisation it was unclear how much of this solution should 
be used for an optimal balance between mucosal visualisation and patient tolerability. 
Beside this, the eff ects of bowel preparation on the transit time of the capsule were 
contradictory, but it was suggested that bowel preparation might lead to rapid 
propulsion of the capsule, again resulting in reduced luminal visualisation.
Ninety patients were therefore randomly assigned to three groups: regular preparation 
(a clear liquid diet followed by an overnight fast), 1 litre PEG based solution or 2 litres of 
PEG solution. The mucosal visualisation was reviewed by two endoscopists who were 
blinded for the preparation regimen. The tolerability of both the preparation and the 
procedure was evaluated in all patients.
The regular preparation resulted in a good mucosal visibility of the terminal ileum in 
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25% of the patients, which improved signifi cantly to 52% and 72% after using 1 and 2 
litres of PEG solution respectively. The improvement of mucosal visualisation did not 
result in an increased diagnostic yield, although a trend towards an increased diagnostic 
yield was observed in IBD patients. Gastrointestinal transit time was not aff ected by 
the preparation regimen. No diff erences were found regarding the tolerability of the 
regular preparation or 1 litre PEG based solution, but preparation with 2 litres was 
experienced as uncomfortable.
These data support the use of 1 litre PEG solution prior to VCE as this signifi cantly 
increases mucosal visibility without discomfort for the patient. If special interest exists 
for the visualisation of the terminal ileum, 2 litres of PEG solution can be considered.
Chapter 3
Chapter 3a describes 250 patients who underwent VCE. The indication was occult 
gastrointestinal bleeding in 150 patients (60%), overt gastrointestinal bleeding in 
27 patients (11%) and suspected Crohn’s disease in 57 patients (23%). All patients 
underwent an uncomplicated procedure and in 76% the entire small intestine was 
visualised. The viewing time was initially 51 minutes but decreased to 30 minutes after 
reviewing 50 procedures.
VCE fi ndings were classifi ed as a defi nite diagnosis when the fi ndings were clinically 
relevant with regard to the indication of the procedure. When it was not clear whether 
the VCE fi ndings related to the symptoms or laboratory abnormalities of the patient, 
they were registered as a probable diagnosis. In case of no abnormalities or an 
insuffi  cient examination, fi ndings were classifi ed as no diagnosis.
A defi nite diagnosis was established in 38%, a probable diagnosis in 32% and no 
diagnosis in 30% of the patients. In case of unexplained gastrointestinal bleeding a 
defi nite diagnosis was found in 33%. The diagnostic yield increased in case of a more 
serious anaemia. The most frequent fi ndings in case of unexplained gastrointestinal 
bleeding were angiodysplasia, erosions and the presence of blood. In case of suspected 
small intestinal Crohn’s disease a defi nite diagnosis was established in 49% of the 
patients. In this group the most frequent fi ndings were ileitis, ulcers and erosions.
The suspected blood indicator (SBI) was evaluated for its accuracy by comparing the 
reviewer’s fi ndings and the SBI fi ndings. The positive predictive value of SBI was 63% 
and the negative predictive value was 78%. This indicator does in its present form 
therefore not appear to be relevant for daily practice.
Chapter 3b presents one of the patients described in chapter 3a with recurrent 
iron-defi ciency anaemia in whom initial VCE had not revealed any abnormalities. A 
second VCE demonstrated the presence of an abnormality in the jejunum. This lesion 
was confi rmed by double balloon enteroscopy and appeared to be a large vascular 
malformation. The lesion was marked using Indian ink and subsequently removed 
surgically. This case illustrates the usefulness of a repeated VCE procedure and the 
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complementary value of VCE and double balloon enteroscopy.
Chapter 4
Although the diagnostic yield of VCE appears to be high, little information is 
available on the clinical consequences of its fi ndings. One year after the performance 
of VCE in 166 patients, a questionnaire was sent to all referring physicians. This 
questionnaire evaluated the clinical consequences of VCE fi ndings. Consequences 
were divided in change of management or unchanged management. Change of 
medication, the performance of an endoscopic or surgical procedure, avoidance of 
additional investigation and other clinical consequences were classifi ed as change of 
management. For all patients the actual clinical condition was compared with their 
condition at the time of VCE and in case of unexplained gastrointestinal bleeding the 
most recent haemoglobin level was registered.
Data of 150 patients were analysed. In 97 patients VCE was performed for unexplained 
gastrointestinal bleeding and in 36 patients for suspected small intestinal Crohn’s 
disease. A defi nite diagnosis had been established in 34%, a probable diagnosis in 
34% and no diagnosis in 32% of the patients. VCE fi ndings resulted in a change of 
management in 38% of the patients, increasing to 59% if a defi nite diagnosis was 
established at VCE. In case of occult and overt gastrointestinal bleeding management 
was changed in 31% and 62% respectively, whereas in case of suspected Crohn’s 
disease VCE fi ndings a change of management occurred in 50%. No relation could 
be established between the occurrence of management changes and the clinical 
condition or haemoglobin level one year after VCE.
Chapter 5
Various studies described that VCE can be useful for the detection of small intestinal 
polyps or solid tumours. We therefore analysed the clinical applicability of VCE for the 
detection of small intestinal carcinoid tumours. These tumours frequently originate in 
the small intestine but are hard to detect due to their small size. Metastatic disease is 
therefore frequently present at the time of diagnosis. Because small primary tumours 
can also lead to complications like stenosis or ischemia, resection is advised even in 
the presence of metastatic disease.
Our study analysed 20 patients with a metastatic carcinoid tumour with an unknown 
primary. All patients underwent extensive evaluation prior to VCE by means of small 
bowel follow through, nuclear imaging and CT scanning of the abdomen. Nuclear 
imaging had been performed using pentetreotide scintigraphy or MIBG scintigraphy 
and had demonsrtrated abnormalities in respectively 65% and 44% of the patients, but 
these techniques could not discriminate whether the accumulation of nuclear activity 
occurred in the mesenterium or in the small intestinal wall. None of the radiological 
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examinations found abnormalities suggestive for a primary small intestinal tumour. 
VCE fi ndings suggested the presence of a primary small intestinal carcinoid tumour 
in 12 patients. In 9 patients a small intestinal tumour was seen, compression and 
ischaemia of the small intestinal mucosa was observed in 2 patients and in one patient 
an area with erosion of the small intestinal mucosa was found. Surgery was performed 
in 7 of these patients, which confi rmed the presence of a small intestinal carcinoid 
tumour in all 7 patients. 
We conclude that VCE is a useful diagnostic tool in patients with a metastatic carcinoid 
tumour and an unknown primary.
Chapter 6
Hereditary Hemorrhagic Teleangiectasia is a genetic abnormality that causes vascular 
abnormalities. Teleangiectasia can occur in the mucosa of the nose and entire 
gastrointestinal mucosa, and arteriovenous malformations can be present in the 
lungs, liver or brain. The two most frequent mutations leading to HHT are mutation of 
the endoglin gene (HHT1) and mutation in the Activin-A receptor like kinase-1 (HHT2). 
HHT1 often has a more serious clinical course than HHT2, and pulmonary vascular 
abnormalities predominantly occur in HHT 1 patients. Anaemia due to gastrointestinal 
bleeding frequently occurs in HHT patients when vascular abnormalities are present in 
the digestive tract. Until recently the presence of teleangiectasia of the small intestine 
could not be assessed and therefore information on this topic is sparse.
In our study described in chapter 6, 25 HHT (14 HHT1/8 HHT2) patients with anaemia 
were analysed by VCE. Data regarding HHT manifestations were collected. Small 
intestinal teleangiectasia were found in all HHT 1 patients, nine of them had large 
teleangiectasia. Five HHT2 patients (63%) also had teleangiectasia of the small 
intestine. In the colon teleangiectasia were only found in HHT1 patients. Four patients 
had previously undergone a gastroduodenoscopy and a colonoscopy without 
abnormalities, but all four did have teleangiectasia of the small intestine.
Our study demonstrates that VCE is a useful diagnostic tool to assess the presence of 
small intestinal teleangiectasia in HHT patients with anaemia. 
In summary the results of our studies, as described in this thesis, give further support 
to the clinical applicability of videocapsule endoscopy. We demonstrated that VCE is 
an endoscopic technique with a considerable diagnostic yield frequently leading to 
changes in clinical management. It can be used in routine clinical care for patients 
with obscure gastrointestinal bleeding and suspected small intestinal Crohn’s disease. 
Beside this VCE is a useful diagnostic tool in specifi c patients with suspected small 
bowel disease, in particular in those with metastases of unknown primary carcinoids, 
and in patients with Hereditary Hemorrhagic Teleangiectasia.
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Hoofdstuk 1
De dunne darm was tot voor kort niet makkelijk toegankelijk voor endoscopisch 
onderzoek. De proximale dunne darm kon onderzocht worden met een push-
enteroscopie en het terminale ileum middels een ileocoloscopie. De enige mogelijkheid 
voor een complete endoscopie van de dunne darm was een operatieve procedure 
waarbij de chirurg de dunne darm over de scoop schuift (intraoperatieve enteroscopie). 
Videocapsule endoscopie (VCE) is een techniek waarbij gebruik gemaakt wordt van 
een capsule van 26 mm lang en 11 mm in diameter die 2 keer per seconde een foto 
maakt van de dunne darm. De capsule wordt ingeslikt en daarna voortbewogen 
door de peristaltiek van het darmstelsel. De foto’s worden doorgezonden naar een 
datarecorder waarna ze als een fi lm bekeken kunnen worden. 
De eerste resultaten van capsule endoscopie waren zeer veelbelovend. In 85% van 
de patiënten werd de volledige dunne darm gevisualiseerd en er werd een diagnose 
gesteld bij 55-85% van de patiënten. Het is belangrijk om daarbij te realiseren dat 
hierbij in eerste instantie geen rekening werd gehouden met de klinische relevantie 
van de gevonden afwijkingen en dat initieel sprake was van een sterke selectie van 
patiënten. Hoewel de klinisch relevante diagnostische opbrengst waarschijnlijk 
dus lager zal liggen, lijkt VCE wel superieur te zijn ten opzichte van radiologische 
afbeeldingstechnieken van de dunne darm en push enteroscopie. Nader onderzoek 
naar de optimale voorbereiding, de werkelijke diagnostische opbrengst, de klinische 
consequenties en mogelijke andere indicaties voor VCE was noodzakelijk en vormde 
de aanleiding voor het onderzoek zoals beschreven in dit proefschrift.
Hoofdstuk 2
Bij de eerste studies met de videocapsule gebruikten patiënten daags tevoren een 
helder vloeibaar dieet en kwamen nuchter naar het ziekenhuis. Al snel bleek dat ondanks 
deze voorbereiding nog regelmatig sprake was van verontreiniging van dunne darm, 
welke de beoordeling van de beelden verstoorde. Hoewel verscheidene studies lieten 
zien dat voorbereiding met polyethyleenglycol-houdende lavagevloeistoff en een 
betere beoordeling mogelijk zou kunnen maken, bleef onduidelijk wat de optimale 
hoeveelheid lavage-vloeistof was. Daarnaast waren de eff ecten van de voorbereiding 
op de passagesnelheid van de capsule tegenstrijdig.
In hoofdstuk 2 wordt een onderzoek beschreven naar de optimale voorbereiding 
voor VCE. In dit onderzoek kregen 3 groepen van elk 30 patiënten hetzij de standaard 
voorbereiding (vloeibaar dieet en nuchter gedurende de nacht), danwel lavage 
van de dunne darm middels 1 liter Polyethyleenglycol (PEG) of 2 liter PEG. De 
beoordeelbaarheid van het slijmvlies en de passagesnelheid van de capsule werd 
beoordeeld door 2 endoscopisten die niet op de hoogte waren van de voorbereiding 
van individuele patienten. Daarnaast werd alle patiënten na de procedure gevraagd 
hoe belastend zij de procedure vonden.
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Uit dit onderzoek bleek dat voorbereiding met PEG de beoordeelbaarheid van VCE 
verbeterde. Na de standaard voorbereiding was de mucosa van het distale ileum goed 
te beoordelen bij 25% van de patiënten. Dit percentage steeg signifi cant naar 52% 
en 72% na voorbereiding met respectievelijk 1 of 2 liter PEG. De verbetering van de 
beoordeelbaarheid van de mucosa resulteerde echter niet in een hogere diagnostische 
opbrengst in de onderzochte patiënten. Een uitzondering hierop vormden de patiënten 
met verdenking op de ziekte van Crohn. Bij deze patiënten werd na gebruik van 2 
liter PEG in 50% van de patiënten een zekere diagnose gesteld terwijl dit in de groep 
met onbegrepen gastrointestinaal bloedverlies slechts 23% was. De verschillende 
voorbereidingen hadden geen invloed op de passagesnelheid van de capsule.
Hoewel de mucosa met gebruik van 2 liter PEG het best beoordeelbaar lijkt, werd deze 
voorbereiding door patiënten wel als belastend ervaren. De standaard voorbereiding 
en de voorbereiding met 1 liter PEG werden gelijkelijk en hoger gewaardeerd dan de 
voorbereiding met 2 liter PEG.
Het gebruik van 1 liter PEG resulteert dus in een betere beoordeelbaarheid van de 
mucosa van de dunne darm zonder dat dit een belasting is voor de patiënt. Wanneer er 
een hoge verdenking bestaat op pathologie van het terminale ileum kan voorbereiding 
met 2 liter PEG overwogen worden.
Hoofdstuk 3
In hoofdstuk 3a worden de eerste 250 patiënten beschreven die een VCE ondergingen 
in ons ziekenhuis. De indicatie voor het onderzoek was onzichtbaar bloedverlies 
uit het maagdarmkanaal bij 150 patiënten (60%), zichtbaar bloedverlies uit het 
maagdarmkanaal bij 27 patiënten (11%) en verdenking op de ziekte van Crohn van 
de dunne darm in 57 patiënten (23%). De procedure verliep bij alle patiënten zonder 
complicaties en bij 76% van de patiënten werd de volledige dunne darm tijdens 
de procedure gezien. Hoewel de beoordeling van de VCE beelden aanvankelijk 51 
minuten per procedure kostte, nam dit door toenemende ervaring na 50 procedures 
af tot 30 minuten.
Bij het bepalen van de diagnostische opbrengst van de procedure werd kritisch gekeken 
naar de relevantie van de gevonden afwijkingen. Afwijkingen werden geclassifi ceerd 
als een zekere diagnose wanneer de bevindingen verklarend waren voor het klinische 
beeld van de patiënt. Wanneer er afwijkingen werden geconstateerd in de dunne darm 
waarbij twijfel bestond over de relatie met de klachten of laboratoriumafwijkingen 
van de patiënt, werd dit geregistreerd als een mogelijke diagnose. Wanneer geen 
afwijkingen werden geconstateerd, de capsule tijdens de gehele procedure in de maag 
bleef of er teveel verontreiniging was, werd dit geregistreerd als geen diagnose.
In de totale groep patiënten werd een zekere diagnose gesteld bij 38%, een mogelijke 
diagnose bij 32% en geen diagnose bij 30%. Bij patiënten met onbegrepen bloedverlies 
uit het maagdarmkanaal werd een zekere diagnose gesteld bij 33%. De diagnostische 
132
Samenvatting
opbrengst was hoger naarmate sprake was van een ernstiger anemie. De belangrijkste 
bevindingen waren angiodysplasiëen, erosies en de aanwezigheid van bloed. Wanneer 
de verdenking bestond op de ziekte van Crohn van de dunne darm werd een zekere 
diagnose gesteld bij 49%. Hier waren de belangrijkste bevindingen ileitis, ulcera en 
erosies.
De software die de aanwezigheid van bloed detecteert werd geëvalueerd op accuratesse 
door vergelijking van de bevindingen van de software en de beoordelaar. De positief 
voorspellende waarde van deze software was 63% en de negatief voorspellende 
waarde was 78%. Vooralsnog lijkt dit algoritme in de huidige vorm slechts een beperkt 
nut te hebben voor de dagelijkse praktijk.
Hoofdstuk 3b beschrijft een van de patiënten uit hoofdstuk 3a met een langer 
bestaande recidiverende ijzergebreksanemie waarbij pas bij de tweede VCE een 
afwijking werd gevonden. Aansluitend werd bij dubbelballon-enteroscopie gezien 
dat er sprake was van een grote vaatafwijking. Deze werd gemarkeerd en chirurgisch 
verwijderd. Deze casus onderstreept het nut om in voorkomende gevallen de VCE te 
herhalen en illustreert de waarde van nieuwe endoscopische technieken zoals VCE en 
dubbelballon-enteroscopie.
Hoofdstuk 4
Hoewel de diagnostische waarde van de videocapsule endoscopie hoog lijkt te zijn, 
is er weinig bekend over de klinische consequenties van de bevindingen. Een jaar na 
het verrichten van de videocapsule endoscopie werd daarom naar alle verwijzende 
specialisten een enquête gestuurd. In deze enquête werden de klinische consequenties 
van de bevindingen bij VCE geëvalueerd. De consequenties werden onderverdeeld 
in beleidswijziging of onveranderd beleid. Er werd gesproken van gewijzigd beleid 
wanneer de bevindingen bij VCE leidden tot een verandering van de medicatie, het 
verrichten van een endoscopische of chirurgische procedure, het vermijden van 
verdere diagnostiek en overige consequenties. Daarnaast werd voor alle patiënten 
de huidige klinische situatie vergeleken met de periode waarin de VCE werd verricht 
en wanneer er sprake was van gastrointestinaal bloedverlies werd het meest recente 
hemoglobine gehalte geregistreerd.
De gegevens van 150 patiënten werden geanalyseerd. Bij 97 patiënten werd het 
onderzoek verricht voor onbegrepen gastrointestinaal bloedverlies en bij 36 patiënten 
wegens de ziekte van Crohn. Een zekere diagnose werd gevonden in 34%, een 
mogelijke diagnose in 34% en er werd geen diagnose gesteld in 32% van de patiënten. 
De bevindingen bij VCE leidden tot beleidswijziging in 38% van de patiënten en dit 
percentage steeg tot 59% wanneer er bij VCE een zekere diagnose kon worden gesteld. 
Bij patiënten met onbegrepen bloedverlies leidden de bevindingen bij VCE tot een 
beleidswijziging in 31% en 62% bij respectievelijk occult bloedverlies en manifest 
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bloedverlies. Wanneer de procedure werd verricht wegens verdenking op M. Crohn 
van de dunne darm werd het beleid op basis van de bevindingen bij VCE gewijzigd in 
50% van de patiënten. Er kon geen relatie worden vastgesteld tussen een verandering 
in het beleid en de ontwikkeling van de klinische situatie of het hemoglobinegehalte 
van de patiënt één jaar na VCE.
Hoofdstuk 5
Diverse studies beschreven dat VCE nuttig kan zijn voor de detectie van dunne darm 
poliepen en tumoren. Dit was reden om een onderzoek te doen naar de waarde van 
VCE voor de diagnostiek van carcinoid tumoren. Deze tumoren ontstaan vaak in de 
dunne darm en zijn veelal gemetastaseerd bij het stellen van de diagnose. Ze zijn vaak 
kleiner dan 1 cm. en daardoor moeilijk te detecteren. Ook kleine afwijkingen kunnen 
echter aanleiding geven tot stenosering of ischemie, zodat aangeraden wordt om ook 
in geval van gemetastaseerde ziekte de primaire tumor te verwijderen.
In dit onderzoek werden 20 patiënten geanalyseerd met een gemetastaseerd carcinoid 
waarvan de primaire tumor onbekend was. Alle patiënten waren eerder onderzocht met 
dunne-darm-passage-foto, CT-scan en nucleaire technieken zoals octreotide- of MIBG-
scintigrafi e. Deze nucleaire technieken detecteerden afwijkingen bij respectievelijk 
65% en 44% van de patiënten waarbij het niet mogelijk is om te bepalen of de afwijking 
zich in het mesenterium of in de dunne darm bevindt. De radiologische technieken 
detecteerden geen enkele primaire tumor in de dunne darm. Tijdens VCE werden bij 
12 patiënten afwijkingen gevonden in de dunne darm die suggestief waren voor een 
primaire tumor van de dunne darm. Bij 9 patiënten was sprake van een tumor in de 
dunne darm, bij 2 patiënten werd compressie en ischemie van de dunne darm gezien 
en bij één patiënt bleek sprake van een erosieve afwijking.
Zeven patiënten werden kort hierna geopereerd waarbij in alle gevallen de bevindingen 
van VCE histologisch werden bevestigd. Deze studie onderstreept de waarde van VCE 
voor de analyse van patiënten met een gemetastaseerd carcinoid met onbekende 
primaire tumor.
Hoofdstuk 6
Patiënten met Hereditaire Hemorrhagische Teleangiectasieen (HHT) ontwikkelen op 
basis van genetische aanleg vaatafwijkingen op diverse plaatsen in het lichaam. Deze 
kunnen voorkomen in neus, longen, lever, hersenen maar ook in het maagdarmkanaal. 
De twee belangrijkste mutaties zijn bekend. De mutatie in het endoglin (HHT1) gaat 
samen met een ernstiger beloop en frequenter voorkomen van vaatafwijkingen in de 
longen. De mutatie in Activin A receptor-like kinase-1 (HHT2) gaat vaker samen met 
vaatafwijkingen in de lever.
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Bij HHT komt ook vaak een ijzergebreksanaemie voor door bloedverlies uit het 
maagdarmkanaal. Omdat de dunne darm tot voor kort niet toegankelijk was voor 
endoscopie is er weinig informatie over het voorkomen van vaatafwijkingen hierin. In 
dit onderzoek werden van 25 patiënten met HHT en anemie gegevens verzameld over 
de diverse lokalisaties van vaatanomalieën. Daarnaast ondergingen alle patiënten 
een VCE. Hierbij werden vaatafwijkingen in de dunne darm gevonden bij alle 14 
HHT1 patiënten, bij 9 van hen bleek sprake van grote vaatafwijkingen. Bij 5 van de 
8 HHT2 patiënten werden vaatafwijkingen in de dunne darm gevonden. Daarnaast 
bleek dat vaatafwijkingen in het colon alleen werden gevonden in de HHT 1 groep. 
Bij 4 patiënten met een normale gastroscopie en coloscopie werden afwijkingen in de 
dunne darm gevonden bij VCE. 
VCE is nuttig bij het bepalen van de uitgebreidheid van de vaatafwijkingen in de 
dunne darm bij HHT patiënten met een anemie. De afwezigheid van afwijkingen bij 
gastro- en coloscopie is geen reden om van VCE af te zien.
Samenvattend bieden de resultaten van ons onderzoek, zoals beschreven in dit 
proefschrift, een onderbouwing voor de veiligheid en klinische toepasbaarheid van 
videocapsule endoscopie. Wij hebben aangetoond dat videocapsule endoscopie 
een veilig onderzoek is met een hoge diagnostische opbrengst en vaak belangrijke 
klinische consequenties. Naast het gebruik in de algemene praktijk voor de analyse 
van onbegrepen gastrointestinaal bloedverlies en M. Crohn van de dunne darm lijkt 
er ook een plaats te zijn voor videocapsule endoscopie bij de detectie van primaire 
carcinoid tumoren en voor het vaststellen van de verspreiding van teleangiectasieen 
bij patiënten met hereditaire hemorrhagische teleangiectasieen.
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AVM  Arteriovenous malformation
CAVM  Cerebral arteriovenous malformation
CD  Crohn’s disease
CT  Computed Tomography
DBE  Double Balloon Enteroscopy
GI  Gastrointestinal
GIB   Gastrointestinal bleeding
HAVM  Hepatic arteriovenous malformation
Hb  Haemoglobin
HHT  Hereditary Hemorrhagic Teleangiectasia
5HIAA  5-hydroxyindole-3-acetic acid
IBD  Infl ammatory Bowel Disease 
IOE  Intraoperative enteroscopie
MIBG  Metaiodobenzylguanidine
MR  Magnetic Resonance
NET  Neuroendocrine tumour
NPV  Negative Predictive Value
NSAID  Non Steroid Anti Infl ammatory Drug
OGIB  Obscure gastrointestinal bleeding
PAVM  Pulmonary arteriovenous malformation
PE  Push enteroscopy
PPV  Positive Predictive Value
SBI  Suspected Blood Indicator
SD  Standard Deviation
VCE  Videocapsule endoscopy
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Figure 1 Videocapsule and its components: 1. lenshood, 2. lens, 3. LED, 4. videochip, 5. 
battery, 6. transmitter, 7. antenna.
Figure 2 The set of aerials receiving the videocapsule signal and the advised positions on the abdominal wall.
Chapter 1
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Figure 3 The belt with the recorder worn around the waist.
Figure 4 The screen of the working station for review of the VCE.
144
Colour fi gures
Figure 2 Images of the second video capsule examination 
at 2 hours and 9 minutes after ingestion showing a solitary 
ulcerating angiodysplasia.
Chapter 3b
Figure 3 a) Double balloon enteroscopy showing a polypous angiodysplasia. b) The location is marked with 
Indian ink and lipiodol.
a b
a b
Figure 4 Histopathological examination showed a large hemangioma-like polypous ectatic vascular 
conglomerate, partly thin walled partly thick walled. ( HE staining, objective 2x en 10x)
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Figure 1 Submucosal mass in the ileum, fi nally diagnosed as a small intestinal 
carcinoid tumour in three diff erent patients (A, B, C). Ischemic small intestinal segment 
due to external compression by a mesenteric carcinoid tumour (D).
Chapter 5
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Figure 1 Small intestinal teleangiectasia detected by VCE in four diff erent HHT 
patients.
Chapter 6
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Toen ik aan het werk met de videocapsule endoscopie begon, wist ik nog niet wat 
er op mijn pad zou komen en dat is waarschijnlijk de reden dat dit boekje er nu 
ligt. Het verschijnen van dit boek was niet gelukt zonder de motivatie en steun van 
talloze mensen om mij heen. Het noemen van namen impliceert het risico mensen te 
vergeten. Mocht ik jou vergeten zijn, bedank ik je bij deze.
Mark Stolk, de stok achter de deur van het proefschrift. Hoe vaak heb je niet bij mijn 
deur gestaan met de woorden “Ik heb nog eens zitten denken………”. Jouw brein bruist 
van de ideeën en zonder jouw stimulans was het schrijven van dit boek voortijdig 
gestrand. Dank voor je motivatie, de gezellige kijksessies en vooral voor jouw inzet 
om dingen af te maken wanneer het mij niet lukte. Ik hoop dat we het werk met de 
videocapsule door kunnen zetten vanuit twee ziekenhuizen.
Ernst Kuipers, enkele jaren geleden werd jij benaderd om mee te denken over ons 
onderzoek met de videocapsule. Hoewel we elkaar niet vaak zagen, wist jij alles vanaf 
een afstand te stroomlijnen. Dank voor je begeleiding en de snelle respons wanneer 
je mijn manuscripten kreeg.
Robin Timmer, de videocapsule wilde je destijds tot mijn speeltje maken. Het 
speelkwartier is over en dit is het resultaat. Bedankt voor je vertrouwen tijdens de 
opleiding in het leukste vak dat er is.
De MDL-assistenten van het St. Antonius ziekenhuis, Claudia Rogge, Frank Vleggaar, 
Geert Dodemont, Jacco Tenthof van Noorden, bedankt voor de altijd gezellige 
samenwerking en natuurlijk voor alle capsules die jullie bekeken hebben.
Henk den Ouden, hoofdstuk 2 is er dankzij jou. Dank voor het randomiseren, verwerven 
en verwerken van data. Succes in de opleiding tot MDL-arts, ik hoop dat je over enkele 
jaren je eigen boekje verdedigt.
Babs Taal, dank voor de samenwerking in het onderzoek bij patiënten met 
gemetastaseerde carcinoiden. Ik vind het leuk dat jij vandaag tegenover me zit.
De Maatschap Interne geneeskunde en MDL-ziekten van het St. Antonius Ziekenhuis 
Nieuwegein wil ik bedanken voor de prettige opleidingstijd.
Ellen van Beaumond, het hoofdstuk van de 1-jaars follow-up is mede te danken aan 
jouw inspanningen. Ik ben ervan overtuigd dat de database in jouw handen alleen 
maar beter gaat worden.
Cees Westermann en Repke Snijder, dank voor het meedenken en aanleveren van data 
voor het hoofdstuk over jullie HHT populatie.
De endoscopie afdeling van het St. Antonius ziekenhuis: Ik kwam en kom graag op jullie 
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afdeling, het waren gezellige jaren. Marlous, Heleen en Ton, dank voor alle patiënten 
die jullie hebben aangesloten aan de capsule.
Ronald Breumelhof, Henk Lam en Marc Verhagen: Ik hoop dat we nog lange tijd op 
deze manier met elkaar kunnen blijven werken. Het was goed om te weten dat ik in 
“times of trouble” op jullie terug kon vallen. 
Maatschap interne geneeskunde & MDL van het Diakonessenhuis: De “s” is eraf. Dank 
voor de prettige samenwerking tot nu toe, voorlopig zijn jullie nog niet van me af.
De endoscopie afdeling van het Diakonessenhuis, een waardige vervanging van de 
afdeling in Nieuwegein. Hard werken kan gezellig zijn, dat laten jullie dagelijks zien. 
Marjon, Marieke en Anja, het Diak capsule team, jullie moeten dit boekje spellen.
De secretaresses en poli-assistentes van het Diakonessenhuis, in het bijzonder Annette, 
Martina en Heleen, dank voor jullie ondersteuning in de voorbereiding van dit boek.
Lieve vrienden en vriendinnen: bedankt voor de gezelligheid die ervoor zorgde dat ik 
energie bleef houden om te promoveren. Hans en Ienke, Jag önskar dig raddalycka i 
Sverige, vi skar är kommande snart.
Hans en Miep, de afgelopen jaren hebben jullie de klussen gedaan die jullie dochter 
bedacht. Dit is de kwaliteit zeker ten goede gekomen en heeft mij extra tijd om te 
schrijven gegeven.
Geert Dodemont: Het delen van frustraties en triomfen tijdens het leren scopiëren 
maakte het leven leuker. Ik hoop dat we nog regelmatig samen het glas heff en. Fijn 
dat je vandaag achter me wilt staan. 
Karin, Bas en Hilke: Zus, zwager en het liefste nichtje van de hele wereld. Ik hoop dat 
we nog veel leuke dingen voor de boeg hebben. Bas, ik vind het fantastisch dat jij 
vandaag achter me staat. Ik ben er van overtuigd de eerste te zijn met een Arienimf.
Ons pap en ons mam: Dit boekje was er zonder jullie niet geweest. Dat geldt zowel 
voor mijn bestaan als voor de onvoorwaardelijke steun die jullie geven. Wanneer ik 
keuzes maakte waar jullie niet achter stonden, gaven jullie me de ruimte om mijn weg 
te gaan. Uiteindelijk ben ik toch dokter en nu zelfs doctor geworden. Ik hoop dat we 
nog lang van elkaar kunnen genieten.
Lieve Carla, jouw veerkracht en optimisme zorgden er de afgelopen jaren voor dat het 
leven ondanks alles leuk bleef. Ik ben blij dat je me bent blijven motiveren om mijn 
proefschrift te voltooien, al is het maar omdat ik nu een boek heb voor jouw schilderij. 
Ik hoop dat we samen nog een heleboel dagen mogen plukken, ik ben blij met je. 

Curriculum Vitae

155
Curriculum Vitae
Bas van Tuyl werd geboren op 27 januari 1970 te Waalwijk. In 1988 haalde hij zijn VWO 
diploma aan het Cobbenhagen College te Tilburg. Aansluitend startte hij in 1988 met 
de studie medische biologie aan de universiteit Utrecht waarvan het doctoraal examen 
in 1994 werd behaald. In 1992 startte hij daarnaast aan dezelfde universiteit met de 
studie geneeskunde. Het doctoraalexamen geneeskunde werd behaald in 1995 en 
gevolgd door het artsexamen in 1997. Na enige tijd gewerkt te hebben als AGNIO in 
het Eemland Ziekenhuis te Amersfoort werd in 1999 de opleiding interne geneeskunde 
gestart. Het eerste deel van deze opleiding werd in het UMC Utrecht genoten (Prof. Dr. 
D.W. Erkelens†) waarna de opleiding werd voorgezet in het St. Antonius Ziekenhuis (Dr. 
H.C.M. Haanen). 
Na bijna drie jaar opleiding tot internist bleek zijn voorliefde voor de maag-darm-
leverziekten te sterk. Vanaf 2002 ging hij daarom in hetzelfde ziekenhuis verder met 
de opleiding tot MDL-arts onder leiding van Dr. R. Timmer. In deze periode werd ook 
gestart met het onderzoek naar de waarde van de videocapsule endoscopie wat onder 
leiding van Dr. M.F.J. Stolk en Prof. Dr. E.J. Kuipers resulteerde in dit proefschrift. Per 1 
januari 2005 werd hij geregistreerd als MDL-arts en sinds 1 juni 2005 is hij gevestigd als 
MDL-arts in het Diakonessenhuis Utrecht/Zeist.

